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INTRODUCTION 
It has been shown many times by various investigators that the result 
obtained from stimulation of the right sympathetic cardiac nerves is quite 
different from the result obtained when the left sympathetic cardiac nerves 
are stimulated. The effect most commonly observed with a right sympathetic 
stimulation is an acceleration of the heart rate. There is often also an aug-
mentation in force of cardiac contraction. The principal effect observed with 
a left sympathetic stimulation Is 2 great augmentation in force of card1a.c con-
tr~ct1on with only a slight acceleration of the hea.rt rate. 
Structurally and chemically, the right sympathetic cardiac nerves seem 
to be no different from the left sympathetic c9rdiae nerves. Why then should 
there be such a difference in the results obtained from stimulation of the two 
nerve supplies? The obvious answer seems to be that the terminations of the 
right and the left sympa.thettc nerves are not uniformly distributed throughout 
the heart. Instead, one area of the heart may receive its innervation primari 
ly from the left sympathetic cardiae nerves whUe another area may receive 
its innervation primarily from the left sympathetic cardiac nerves. 
It Is widely accepted at the present time that norepinephrine is the actual 
chemical transmitter released at the endings of post-ganglionic sympathetic 
adrenergic nerves. Therefore, the concentration of norepinephrine in a 
tissue should give an indication of the relative concentration of adrenergic 
nerve endings in that tissue. 
v 
In t.lte present study, cardiac tissue was analyzed for its content of 
epinephrine and norepme}:ilrine using the fiuorimetric method. of analysis. 
vi 
It was found that a partially sympathectom1zed heart has a lower concentra-
tion of norepinephrine than does a normal beart. This result was to be ex-
pected since the norepinephrine present In the heart is presumably released 
from sympathetic nerve endings. Small samples of cardiac tissue were 
analyzed for their content of norepinephrine in an attempt to determine which 
areas of the heart are innervated by the right sympathetic cardiac nerves 
and which areas are innervated by the left sympathetic cardiac nerves. 
CHAPTER I 
REVIEW OF THE LITERATURE 
A. Role of Epinephrine and Norepinephrine in the Mammalian Organism 
The concept that norepinephrine is the neurohumoral transmitter re-
leased at the nerve endings of sympathetic adrenergic post .. ganglionic nerves 
has only recently been elucidated. In 1904, after studying the adrenalecto-
mized animal and comparing it with the sympathectomized animal, Elliot 
made the following statement, "Adrenaline might then be the chemical stimu-
lant liberated on each occasion when the 1m.pluse arrives at the periphery. 't 
This statement is the first direct suggestion that sympathetic nerve activity 
might include the release of a highly active prinCiple at the nerve endings, a 
"humoral transmission" (243). In 1905, Elliot extended his experimental re-
search on the action of adrenaUne and was able to show that the action of 
adrenaline on sympathetically innervated organs mimics the effect following 
eXCitation of the sympathetic nerves supplying that organ. For example, he 
found that adrenaline accelerated the heart as did the cardiac accelerator 
nerves. It constricted the blood vessels of the body unequally; but to much 
the same extent in the various organs as did excitation of the sympathetic 
nerves. Further be found that degeneration of the sympathetic nerves did not 
abolish the action of adrenaline. In fact, it seemed to increase the sensi-
tivity of the organ to adrenaline. He also observed that neither the nerve 
cells, nerve fibers. nor the contraeWe muscle fibers could be irritated by 
1 
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adrenaline. Therefore, he suggested that the stimulation takes place at the 
jW1ction of the muscle and the nerve (67). 
It was not untU 1921 that Loewi provided the experimental evidence 
necessary to substantiate the theory proposed by Elliot concerning neuro-
humoral transmission. His experiments proved the existence of specific 
substances liberated from cardto-blhibitor as well as cardia-accelerator 
nerve fibers on stimulation. Mer these decisive findings a research was 
commenced which aimed at the It:!e~tUication of these neurohormones. 
Loewi's "Vagusstoff" was soon identified as acetylcholine. However the 
chemical nature of the sympathetic transm.itter substance, .Loewlt s "Aecel-
eransstoff", was not so easily determined. 
In 1910, Barger and Dale published the results of an extensive study in 
which they reported a relationship between chemical structure and the 
"sympathomimetic fl action of a great number of aroines. Among 55 com-
pounds tested, amino-ethanol-catechol (norepinephrine) exerted the strongest 
action on the blood pressure of a decerebrate cat. The authors stated that 
their results were compatible with the concept proposed by Elliot p)stnlatlng 
the existence of a myoneural junction, the function of which is to receive the 
nerve 1mpluse or the chemical stimulant substance. Further, they stated 
that this chemical substance liberated at sympathetic nerve endings produces 
effects which correspond very closely with the action of norepinephrine (22). 
In 1933, Cannon and Rosenblueth postulated that there may be two types 
of sympathetic humoral agents, an excitatory one and an inhibitory one. 
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They theorized that there is probably only one substance released by the 
sympathetic nerve when it is stimulated. This substance they call substance 
M. However this substance can then unite in the effector cell with an excita-
tory substance, substance E, 01' an inhibitory substance, substance 1 This 
combination results in the formation of the active "sympathin". Thus, a com-
bination ME produces sympathin E, the excitatory sympathin, wblle a com-
bination MI produces sympathin I, the inhibitory sympathin (45). 
stehle and Ellsworth, in 1987. reported the results of experiments In 
which they studied the effect of norepinephrine in decapitate cats. They 
found that the response agreed with that produced by stimulation of the hepatIC 
nerves. They therefore suggested that norepinephrine may be the substance 
released when the hepatic sympathetic nerves are stimulated. However, they 
stated that their experiments did not show whether norepinephrine alone was 
efiectlv'e or whether it reacted with a tissue substance to form sympathin E, 
which was then directly responsible for the effect (258). In 1938, Greer and 
co-workers, reported a close correlation between the response to norepl-
~epbr1ne and the response to the substance released by the I1ver following 
hepatic sympathetic nerve stimulation (124). 
In 1946, von Euler published his observation on spleen extract. He 
found that extracts of fresh cattle spleen possessed pressor activity and that 
this extract closely resembled norepinephrine in its action. Biological tests, 
color reactions. and fluorescence reactions all indicated that the substance 
Involved was norepinephrine (72). In the same year he piblished a study of a 
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sympathomimetic substance in extracts of mammalian heart. in which be 
concluded that the substance responsible for the sympathomimetic actions in 
the heart extroots is intimately related to some substance resembling nor-
epinephrine (73). Von Euler also made an extensive study of nerve tissue 
extracts. He found that extracts of thoracic Ilnd lunlbar sympathetic chains 
and the splenic nerves possessed a large pressor activity which was similar 
to norepinephrine. He also suggested th~t the norepinephrine in sympathetic 
nerves may be bound to lipids (74). 
In 1947, von Euler and Schmiter low showed that the normally oecuring 
pressor substance in bovine and human blood resembles norepinephrine (101), 
and in 1948, Schm1terlow showed that the pressor activity in extracts of 
blood vessels behaved like norepinephrine. Through histological studies. he 
also showed a correlation between the amount of pressor substance and the 
amount of nervous structures present (243). 
Baeq and Fischer studied the biological effects of various tissue extracts. 
In splenic extracts they found a high content of a pressor substance which 
seemed to be identical with norepinephrine. They also found a substance 
baving the properties of norepinephrine in extr9.Cts from the sympathetiC 
chain, splenic nerves, and stellate g~nglton (21). 
In 194.8, von Euler analyzed extracts of splenic nerves using bio1\ssay 
and colorimetric analysts. He found that the amount of I-norephinephrJne in 
splenic nerves was Hl-:!.5 u g!.:l per gr~)m of nervous tissue. He also found 
0.5 u gm of epinephrine per grnm of nervous tissue (75). 
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As more and more evidence accumulated, the concept that norepinephrine 
may be the actual sympathetic neurotransmitter began to be accepted. The 
epinephrine and norepinephrine content of various tissues and organs was 
measured. Epinephrine-producing chromaffin cells were found in various 
organs of the body. All adrenergic nerves were found to contain large 
amounts of norepineJilrine. However, very small amounts of epinephrine 
were also found in adrenergic nerves (76). Goodall, in 1950, reported the 
results of a colorimetric ~npJ.ysi3 of beef he3rt extracts. The auricles were 
found to contain 0.40 u gnl of norepinephrL,e per grn.m of tissue and 0.04 u 
gm of epinephrine per gr~m of tissue. On the other hand, the ventricles con-
tained O. 30 u gm norepinephrine per gra,m and O. 07 u gm epinephrine per 
gram (113). 
Outschoorn, in 1952, studied the corona.ry sinus blood of dogs nfter 
stimulation of the cardiac symp~thetic nerves rJld reported signtftcant liber-
ation of norepinephrine into the coronary blood. 'lb.e plasma level of nor·· 
epinephrine rose from a control level of 2. 5 u gm per liter to a level of 7. 5 
to 10.0 u gm per liter after sympathetic stimulation (212). 
WeU-Ma1herbe has shown that a large percentage of the epinephrine and 
norepinephrine occurring in plasma is associated with the blood platelets. 
His experiments demonstrated that when the plasma was centrifuged at 600 g, 
the platelets remained in suspension and the plasma, content of epinephrine 
was 1. 47 u gm per UteI' while the norepinephrine content was 4. 25 u gm per 
Uter. When the plasm,. was centrifuged at 3000 g, the platelets preCipitated 
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and the epinephrine content of the plasma fell to O. 34 u gm per liter while 
the norepinepbrlne content fell to 1. 20 u gIn per liter (284). He also observed 
that, in heparinized blood, clumping of platelets occurs and results In low 
plasma levels of epinephrine and norepinephrine (287). However, Vendsalu, 
in his studies on epinephrine and norepinephrine in humpn plasm~, was un-
~ble to find any difference between platelet-rich plasmp. (centrifuged at 150 g) 
pM pla.telet-poor pi9sma (centrifuged at 16, 000 g) (271). 
In general, the amount of norepinephrine has been found to vary greatly 
from organ to organ, but it can be correlated with the extent of the sympa.the-
tic nerve supply to an organ. Accordingly, the spleen bas been shown to be 
comparatively rich in norepinephrine, while the lung and striated muscle con-
tain small amounts. In nerve-free placenta, no norepinephrine can be found. 
The norepinephrine content of various peripheral nerves also varies with the 
amount of post-gAnglionic sympsthetic nerve fibers in the nerve trunk. The 
concentration of norepinephrine in nerve endings is far higher than in the nenE 
trunk itself (79). 
The brain also contains significant amounts of norepinephrine, the high-
est concentration being in the hypothalamus. The gray matter around the 
aqueduct, the tegmentum of the midbrain, the meduallary reticular formation, 
and the medial part of the thalamus also contain considerable amounts of nor-
epinephrine. The rem~dnder of the brain however conta.tns very little nor-
eptnephrlne. The histological site of formAtion and/or storage of norepineph-
rine In the brain is unknown; it may be situated in nerve cells, non-
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medullated fibers, glia, or at several of these sites. Maeroseoptc~lly, there 
is a high concentration of norepinephrine in all parts which eonta.in the central 
representation of the sympathetic system. It has been shown that norepineph-
rine is lost from the hyp:>thalamus whenever the sympathetic centers 
situated there are vigorously stimulated (273). 
An analysis of the norepinephrine content of any tissue necessitates an 
extraction of the noreplneJ;ilrine from the tissue followed by analysis of the 
tissue extract. Recently, however, Carlsson has developed a new histo-
chemical method for visualization of norepinephrine in tissues. It involves 
the use of a fluorescence microscope and is many times more sensitive than 
previously available histochemical methods (48). Through utUtzatlon of this 
technique, it is conceiv9.ble that our knowledge of the distribution of nor-
epinephrine in various tissues will be greatly enhanced. 
B. Biosynthesis of Epinephrine and Norepinephrine 
The pathway of formation of epinephrine and norepinephrine, as it is 
generally accepted toda.Ytls as follows: 
HO-O 
HO-O' HO- ~ 
HO-O 
HO- " 
Ho-Ol HO-
HO-
HO-
-CH -CH-NH_ 2 , ---""2 
CooH 
~ 
- CHa -'~H-NH2 
COOH 
i (dopa dec9rboxyl?se) 
-CH -CH-NH 222 
~ (dops,m1ne-B-oxidase) 
- 9H-CH2-NH2 
OH 
Tyrosine (Hydroxy-phenylalanine) 
Dopa 
(Dihydroxy-phenyblnnine) 
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Udemriend, in 1956, showed that phenylabnine, tyrosine, and dopa. could 
net as precursors of ~drellDl epinephrine flnd norepinephrine hI the rat. '!his 
was the first dJrect evidence for the role of tyrosine And of dopa in the syn· 
thesis of epinephrine !L.Tld norepinephrine (267). The intermediate between 
dopa and norepinephrine was JX)stulated to be dopamine because the enzyme 
dopa. decarboxylase had been found in the adrenal medulla. 
Goodall, in 1957, reported on a study in which minced bovine or canine 
sympaiJ;..atlc nerves, sympathetic g:mglta, or parasympathet1e nerve& were 
Ll1C'..1batad with C-14 labeled tyrosine or C-141abeled dopa. It was found that 
both bovine and carrlne sympathetic nerves and ganglia when incubated with 
either labeled tyrosine or labeled dopa, formed radioactive dopamine and nor-
epinephrine. A very slight amount of radioactive epinephrine was also formec: 
Vagus nerves eould form radloa.etive dopamine when incubated with labeled 
dopa but not when incubJi,ted with labeled tyrosine. No epinephrine or nor-
epinephrine could be formed in etther case (117). In a study on adrenalglllld 
tissue, Good"ll found tha.t the formation of norepinephrine from dopsmme re-
quired. oxygen both in tissue sl1ces ~nd in homogenates. Adrenal sltces 
formed epinephrine, norepinephrine, nnd do}»,mme from labeled tyrosine. 
Dopa.mine wr,$ suggested ".8 the precursor to norepinephrine. Both dopa nnd 
dopamine could be used by the adrenal gbnd for the synthesis of norepinepht 
r1ne p.Jld epineJ;i1rine (118). Therefore, Goodill proposed that the following 
pa.thway oc:mrs both in the adrenal medulla and in sympathet1e nerves and 
pIlIl1a.: Phenylalanine ---J tyrosine ~dopa ~ dopamine ~ norepinephrine ~ 
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epinephrine (119). 
The decarboxylation of dopa to dopamine by dopa decarboxylase appears 
to take piPce in the extr~grl:'..nular portion of the adrenal medullary cell. Re-
cent evidence indicates thnt the chromaffin granules of the adrenal medulla 
3.re the actual site of norepinephrine synthesis from clapp-mine. The mecha-
nism involved is not known. However, it would appea.r that the chromaffin 
granules thus serve not only as 9. storehouse for epinephrine f'll1d norepineph-
rine but are actually the site of norepinephrine formation from dopamine. If 
the norepinephrine is formed in the interior of the granules it would have to 
diffuse into the clear cytoplasm, there be methylated, and then re-enter the 
chromaffin granules (120). This sequence would be slow and may a.ccount 
for the slow restoration of the epinephl-ine content of the adrenal gland whleh 
many authors have observed following depletion. 
'lbe intracellular localization of epinephrine and norepinephrine has re-
cently been the subject of many investigation s. In studies on the perfused ox 
spleen, Eliasson showed that a change in the reaction of the perfusing fluid to 
the acid side using naturally occurring acids such as ascorbiC, lact1e, and 
citric acid caused a release of norepinephrine from the spleen. Extra re-
lease of norepinephrine could be observed even when the pH of the perfusate 
fell only from 6. 9 to 6. 6. Changes of this order could occur In vivo In con-
ditions of hypoxia or reduced elrculation. It had previously been shown by 
HUlarp that adren91 medullary granules lost their eatechola,mines during 
treatment with acids. Therefore Eltasson postulated that, if slmUar struc-
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tures were present in sympathetic nerves, they may act in the same way. 
Nerve stimulation may cause a change in the membrane structures so that 
the contents of the granules are released (66). In an extension of the same 
study, von Euler showed that surface active agents such as detergents in-
creased the release of norepinephrine from the perfused ox spleen. These 
same agents had been shovm by Hillarp to release catecholamJnes from the 
granules of the chromaffin cells (102). 
Norepinephrine is present not only in the axons of the nerve but also in 
the cell soma, as indicated by the fact that extracts of thoracic sympathetic 
ganglia contained approxtma.tely the same amounts of norepinephrine as did 
the fibers. It seems unlikely that the transmitter occurs free in the axonal 
tissue which conhins amine oxidase and possibly other destructive enzymes. 
It w~ s therefore suggested by von Euler R.nd others that the transmitter is 
located in some specific structures within the axon rather &.an existing free 
in the axoplasm. They theorized that if norepinephrine were stored in such 
hypothet1eal structures, these might be distributed in a pattern similar to 
that actually f()UJld for norepinephrine. In this way the accumulation in the 
terminal parts could be satisfactorUy explained. 
Von Euler and HUlarp, in 1956, reported a study on homogenized spleen 
tissue and splenic nerves. 'Illey subjected the suspension to fractional cen-
trifugation. A fine granular sediment was obtained which contained norepi-
nephrine in a bound and protected form similar to that in the adrenal medulla. 
When this sediment was suspended in neutral isotonic saline, no noreplnepb-
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rine 2Ctivity could be detected. However if the pH was changed to 4 or lower, 
the norepinephrine went into solution. :Heating or the addition of detergents 
r:1so caused l"ele::tse of norepinephrine. It is postulated that these nerve 
grR.l.'1ules, which store the trgnsmitter, may ~!so have the ~bUity to synthesize 
norepinephrine. l"'llUS, the chemic~l tr~msmitter of the adrenergic nerves is 
believed to be stored intr~.-axon;;lly in structurru. units which can'be separat-
ed from the rest of t'fJ.e ~xonal tissue. If these structures fllso synthesize the 
trp,nsmitter, this synthesis must proceed at a high rate shlce adrenergic 
nerves are capable of rele3.Sing their neurotr~nsmitter substance continuous-
ly on :;tir~uh.tion over ;;1 period of ms:ny hours. 'rhe rate of axoplasm flow is 
not tlUfficiently high to explain the rapid replenishment of the transmitter. 
'')n the ot.her hand, it is possible Ulat the g'ranules are continuously moving 
from the pericaryon to the periphery. There is no reason to suppose that 
the granules leave the axon during stimulation; they probably only discharge 
their contents. Apparently the norepinephrine is well protected In the gran-
ules, since an organ Uke the spleen can be stored over a day at room temper-
ature without any appreciable loss of norepinephrine. It has been shown that 
heart tissue can be stored at room temperature up to six hours before sig-
nificant losses of norepinephrine oceur (1.47). 
'lbe mechanism of release of the transmitter 1s unknown. It has been 
suggested th~t the ammes ~~re bound to proteins. The possibility of an intra-
p.xou",llonic shift In connection with the nerve excitation volley, as '" factor 
causing the necessary alteration in the binding CApacity of the granules, 
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might be ~onsidered ns 9 .. working hypothesis. Relatively high amounts of 
transmitter :Jre found in the nerve trun..\. The presence of the transmitter 
here seems to have no function. It probably has nothing to do w1tbcolYJuctton. 
The intra- sxo!l.~l structures containing the trnnsmltter t~re probably present 
~]ong the whole length of the neuron. Apparently they are accumulated at the 
endings, ju1gbtS :from the relp.iive amounts of norepinephrine in the axon and 
in the organ.. ~ince such granules have been denlOnstrated in homogenates of 
adrenergic nerves, it might be postulated that they are formed in the area 
ar:Jtmd the n.ucleus and then tr~U1sported to the periphery. It has been demon-
strated that the ax.oplasm now is not rapid enough to replenish the amounts of 
trmsmitter which rt.re released at the pel~ipherYJ but what it could do is re-
phce the structural un:its which could then synthesize the transmitter at a 
high rate. ".Vben a p08t ganglionic ldrenergi<: nerve fiber is cut and the distal 
end stimulnted, there continues to be un appreciable amount of norepinephrine 
rele~sed from the nerve endJng itself. The question arises whether this is 
due only to rele~.se of stored norepinephrme or whether the nerve ending is 
indeed syntheSizing the tr~nsmitter (82). 
HUlarp has recently m3.de further invest1g~.tions on the granules of the 
a.drenal medulla. He has shown thRt the cytoplasmic granules are O. 1 to O. 6 
u in diameter and have a high density. They h~ve a membrane which is im-
permeable to proteins but permeable to sm811 ions and molecules. They 
wldergo lysis in hypotoniC media with insbnt'Uleous release of eatecholamines 
These amines are normally bound within the granules in a non"'({iffusable state 
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Each A TP molecule probably holds four amine molecules by electrostatic 
forces. A protein component is probably also tnvolved in the complex. This 
postulated storage complex breaks down immediately when the granule mem-
brane is ruptured. During an in vivo stimulation, the aroines and ATP are 
liberated from the storage complex without any release of t'le intragranular 
proteins (139). 
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C. Metabolism of Epinephrine and Norepinephrine in Various Organs 
Little was known of the fate of norepinephrine and epinephrine in the boct, 
untll recently. It is now generally accepted that norepinephrine and epineph-
rine are metabolized by a combination of f)-methylation and oxidative de-
amlnatlon to yield the following major metaoolite3: 1) normetanephrme and 
metanepbr!ne, the 3-methoxy analogues of the amines, 2) 3-methoxy - 4-
hydroxy-mandelic acid, and 3) 3,4-dihydroxy-mandel1c acid. 
1\11ono -amine oxidase was shown by Blascbko, in 1937, to cause an oxida-
ttve deamlnatlon of norepinephrine ad epinephrine as well as mrny other 
~m1nes. The enzyme is present in mpmmalipn liver and n.rious other orgmu 
It can be demonstnted in all vertebrates 9.00 in many invertebrates (33). 
M~ny studies were carried out by various investigators in ~n attempt to deter 
mine whether mono-amine oxidase was the enzyme responsible for the m-
activatlon of norepinephrine and epinephrine in vivo. An effort was made to 
apply to mono-amine oxidase at the adrenergic aerve endtngs a function 
similar to that of cholinesterase at ehoIb't8rg1c endings. 
Schayer studied the metabol1sm of epinephrine eontaintna' isotopic carbon. 
He concluded that about 50% of administered eptnepu.ine In the rat is inac-
tivated by loss of methyl-amine, presumably through the action of amine oxi-
dase (241). Bum Investigated the effect of sympathetic denervation on the 
tissue content of mono-amm.e oxidase. In studies on the nictitating mem~ .. sw_ 
he found a fall tn the amount of mono-amine oxidase after degeneration of the 
sympathettc fibers. The fslI1n enzyme content could be correlated with the 
.... 
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magnitude of the Increased sensitivity of the denervated membrane to nor-
epinephrme and eptnephrlne (41). 
In studies on the perfused ox spleen, von Euler showed that amine oxidase 
Inhibitors did not increase the release of norepinephrine from the perfused 
spleen. However they did increase the yield following nerve stimulation (90). 
In studies on ltver tissue in vitro, it was shown that norepinephrine formed 
oxidation products indicating attack by mono-amine oxidase. However, the 
substance 3, 4-dihydroxy-norephedrine formed no such products IndJ.eatlng no 
a.ttack by mono-amine oxidase. When a study of the urinary excretion of nor-
epinephrine and of dihydroxy-norephedrine in man was made, it was found 
that 3. 8% of the norepinephrine and 3. 6% of the dlhydroxy-norephedrine was 
excreted in the free form. Von Euler concluded that, since the dlhydroxy-
norephedrine was inactivated to the same extent as the norepinephrine aI .. 
, 
though it is not attacked by mono-amine oxidase, some other enzyme system 
must playa role in the destruction of ctrculating catecholamines (90). 
In 1957, Armstrong isolated 3-methoxy-4-hydroxy ... mandel1c actdfrom 
urine, Axelrod isolated normetanepbrine and metanephrine from urme, and 
von Euler found S ... 4-dthydroX}"1nandellc acid in urine. And, In the same year, 
Axelrod rep)rted the isolation from rat liver of an enzyme whJ.eh catalyzes 
the O-methylation of norepinephrine and epinephrine. He called this enzyme 
e ateehol .. O .. methyl transferase (4). 
'lbese findings suggested three possible pa,tbways for the meta,boUsm of 
catecholamine.: 1) oxidative deamlnatlon followed by O-methylation, ;~) 0-
17 
methylation followed by oxidative deammation, or 3) both reactions occurlng 
stmultaneously. Many experiments were performed in an attempt to deter-
mine which pathway predominates in the in vivo metabolism of c9techolamines 
However, it may wen be tha.t the relative importance of each mechanism 
varies from tissue to tissue and from species to species. Through studies 
of urinary metabolites, Axelrod has shown that major pathway for metabolisn: 
of exogenous circula.ting norepinephrine and epinephrine is O-methyla,tfon 
fcUowed by oxidative deaminatton. This was found to be the case in man and 
tn the rat (7). 
In vitro studies with both rat liver and rat brain showed that O-m.ethyla-
tion was the predominant mechanism for metabolism of catecholamines in 
these tissues. A study on the distribution of catechol-O-methyl transferase 
in monkey tissue showed that the highest concentration Is in the liver. High 
concentrations were also found in the bra.in, spleen, blood vessels, and 
peripheral nerves (6). It Is probable that, in these tisswts, O-methylation is 
indeed the most important meta,bol1c pathway. Oxidative deamtnation by mono 
amine oxidase may play only ~, minor role. It seems that the main function of 
mono ... a mine oxidase m3Y be the oxidative deamin~tion of normetanephrtne and 
metanephrine. These two substances are actually better substrates for mono-
amine oxidase than are norepinephrine and epinephrine. 
In circula.ttng blood and in the tissues mentioned above - liver, brain, 
spleen, blood vessels, and peripheral nerves - it has been clearly demon-
strated that metabolism of catecholammes takes place principally by means 
I""" 
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of O-methylatlon. However ~ in the cue of other tissues (for example, the 
heart) this may not be true. In 1960, Goldstein. published a comparison of 
metabolism of epinephrine and norepinephrine in the heart and in the liver. 
He found the catecholam1nes are to a large extent metabolized by mono-amine 
oxidase in the heart. 'l11e O-methyl transferase activity of the heart is much 
less than that of the liver. Goldstein concluded, therefore, that cateehol-
aroines in the heart are metabolized to a greater extent by mono-amine oxi-
dase than by O-nlethyl transferase. In the liver, O-methyl transferase seem 
to be the enzyme responsible for inactivation of catecholamines (112). 
Crout, in 1961, showed that the mono-amine oxidase activity of the rat 
heart was five times the catechol-O-methyl transferase activity. Mono-
amine oxidase Inhibttors were shown to cause a significant increase in the 
norepinephrine level of the heart. A catechol-O-methyl transferase inhibitor 
had no effect on heart catecholamines. Injections of norepinephrine were 
given to the rats and the norepinephrine content of the heart and the cir-
culating plasma were measured. In the presence of a mono-amine oxidase 
inhibitor, norepinephrine accumulated in the myocardium while elearance of 
norepinephrine from the circulating plasma was relatively unaffected. Bow-
ever, if catechol-O-methyl transferase were inhibited, the abUlty of the rats 
to metabolize eirculating norepinephrine was severely impaired (61). 
It seems, therefore, that any consideration of the metabolism of eat-
echolamines must take into account the particular tissue involved and also 
the speeies concemed, since wide variations in metabolic pathways have beet! 
--
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de.E1onstr::tted from one tissue to another f'nd also between various species. 
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n. t'lfJ.uence of the Sy~p3thet1C Nervous System on C::trdiae Fu...llction 
Hunt, In 1899, professed th.e view that the heart is under a continual In-
fluence of sympathetic impulses. This view of Hunt is today !!Ul. accepted fact. 
Bronk was among the first to demonstrate t.~e presence of continuous e.ction 
poten.tials ill the cardiac syIDlk1.thetlc nerves. He t.c~o1ated one of the nerves 
running from the stellate gangl10n and transected it. The proximal portion 
V!~tS then attached to R brush electrode, nllOVling the recording of efferent 
8::rm~thet1e impulses (36). 
In 1.945, Shipley and Gregg demonstr,ted that stimulation of the sympa-
thetic cardiac nerves caused the heart to be~t more vigorously, increased 
the cardiae output 911d the blood pressure, increased the coronary flow, and 
increased the eoron~ry A-V oxygen difference. 'nley postulated that the 
cardiac sympathetic nerves must liberate a cardb.e stimulating substance 
(250). 
Randall found that stimulation of the cardiac sympathetic nerves pro .. 
duced a large elevation in systolic blood pressure with 0. lesser elevation in 
diastoUc pressure. Thus, a stgntfieant increase in 1111se pressure occurred. 
The elevation of blood preSSl.1r e was shown to be 'produced princ tpally by an 
augmentation of ventricular contraettonrather than by cardiae acceleration. 
(230). Randalllu\s further dem..:!7tstrated that accelerator fibers are more 
prominent in the right cardiae sympathetic nerves while augmentor fibers 
are more prominent In the left cardiae sympathetic nerves. These accelera ... 
tor and augmentor fibers could not be functionally differentiated at any point 
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in their anatomical pathway from the spinal cord to the heart. The classifi-
cation of a nerve fiber as accelerator or augmentor was believed to be deter-
n:dned by its site of ter:mination in the heart (229). 
In a study in which cardiometer l'ecOrdings were analyzed, Kelso reperte4 
that sympathetic stinmlation produced an increase 1.."l. both the rate and the 
volume of ventricular systolic ejection. There was a smaller end .. systolie 
volume with no significant change in the end-diastolic volume. By stimula-
tion during isovolumetric conditions in the ventricles, it could be demon .. 
strated that the augmentation depended prhnarUy on changes in contraction of 
the myocardium rather than on alterations in either the peripheral resistance 
or the initial distension of the ventricles (162). 
Sarnoff has shown that stellate ganglion stimulation augments tbe strengtlJ 
of atrial contraction and thus the atrial contribution to ventricular fWing. 
The augmented atrial contraction was shown to take place in a shorter period 
of time. In addition, 1t was demonstrated that the power produced by the 
ventricle from any given mean atrial presaure was increased by stellate 
ganglion sttmulatlon (23'1). 
'lbe importance of the sympathettc innervation to the heart bl inc reasing 
the amount of work whIch may be done by the heart seems to be readily evi-
dent. 
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E. Sympath.ectomy r.nd Possible Regeneration of Syr41:t=athetic Nerves 
The sympathetic nervous supply of the he~trt has been studied in considel'-
able detail. It is nOT1 generally agreed thnt the pre ... gangllonic neurons have 
their cell bodies in the intermediolateral cell coluIl.1l1 of the spinrl cord from 
the levels T1 through T5. These celts send fIbers Yitl the white r~mi of the 
upper five thora.cic nerves to termL"'late in the cervicol J1nd upper five tho·· 
rrlcic ganglia of the sympathetic trunk. ":he post-ga.."lglionic neuronB may 
l'uve their cell bodies in 211Y of tile above mentioned synlpathetic g~nglia. The 
main P3.thwas taken by post-gp.nglionic fibers to the heart is "vb the stellate 
ganglion, a combination of the inferior cervical g~nglion :uld the f1r3t thoraeic 
ganglion. I'Aany supplementary r.i{thw~ys hAve been described, however, and 
it is possible L\at fibers from each of the cervical and upper five thoracic 
ganglia may reach the heart without pp..ssmg through the stellate ganglion. 
Gaskell,. in the 1880's,. reported several studies on the innervation of 
the heart in cold-blooded R.'1imals. He found that, when he stimulated the 
vagus nerve in the frog, be could produce eit..1ter an acceleration or a slowing 
of the be art rate. However he later found that this nerve was actually a 
combt.lation of t..'le vagus and sympathetic nerves. By careful ma'1ip.tlation, 
the vagus and sympathet1ccnu1ponents could be separ:ated. stimulation of the 
sympathetic before it combined with the vagus produced purely augmentor 
effects. Stimulation of the vagus before it combined with the sympathetic pro 
duced purely inhibitory effects. The effect of sympathetic stimulation in the 
frog 'Wa.S a marked acceleration and a..'l. ~ugmel1tation of the contractions of 
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both auricles and of the ventricle (107). 
Flack, in 1910, showed that the vagus and sympathetic nerves exert 
their effect on heart rate by way of the sino-auricular node. If the S-A node 
were frozen, the acceleration or the s]owing of the heart rate could no longer 
be obtained (104). Woolard, in 1926, showed that the auricles and the A-V 
bundle are supplied by both parasympathetic fibers and sympathetic fibers 
while the ventricular muscle is supplied by sympathetic fibers only (294). 
He showed that, in the auricles, fibers from both systems appear to end 
intramuscularly. 'lb.e fibers seem to spin a plexus around the muscle cell 
and ultimately enter the protoplasm of the muscle. 
Kuntz showed that in man a discrete inferior cervical ganglion very 
rarely occurs. This ganglion is commonly fused with the first thoracic gang-
lion to form the stellate ganglion. Sometimes the second thoracic ganglion 
is also incorporated in the stellate ganglion. Kuntz reported 9, study of 
cadavers and still-born fetuses in which he found that C1lrdiac sympathetic 
nerves may arise from the upper thoraCic segments of the sympathetic trunk 
as welllls from the cervical and stellate gangUa (179). White, in 1933, found 
the same situation to exist in the dog. He showed that the upper thoracic 
ganglia send fibers directly across the posterior mediastinum to the poStertor 
cardiac plexus (292). 
Kabat, in 1937, demonstrated that sympathetic cardia-accelerator fibers 
are present in the vagus nerve. When the vagus nerve was stimulated after 
treatment with atropine, cardiac acceleration was produced (154). Nonidez, 
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in 1939, reported ~ thorough study of the inllerv?tion of the he~rt. He showed 
tb1't the superior c::\rdl;lc nerve, which originstes from the middle car/ier,l 
g~ngUon, does not rerch the hap-rt, but ends on the w<::>l!s of brge r>rteries. 
The middle ct>rdif'c nerve cr'rries most of the symp~thetic supply to the h~rt 
The inferior c"rdi~c nerve W~'S found to cf'rry o:'ffereut fibers from the her-rt. 
Nonidez ~lso observed that the vagus nerves cl'rrled sympf\thetic post-gang-
lionic fibers (209). 
The precise site of termination of the motor fibers in the heart h~3 not 
yet been clearly demonstrated. Nonidez questioned the existence of ~ .. nervow 
"termmpl reticulum" in the heart, In which the vagus find sympathetic flbers 
merge into 2. syncytium of neurofibrUs. HUlarp proposed that the innerva-
tion apparatus may consist of a nervous ground plexus, within which terminal 
axon ramUications are running. He theorized that each axon might innervate 
a certain number of cells which then react as a functional unit. 'Ibis unit 
supposedly would not be innervated by one neuron alone, but by several 
neurons. By means of thts overlap, the response of the autonomic effector 
system could be modified both by temporal and by SPfttial summation effects 
(135). Kuntz, however, pointed out that individual nerve fiber termmations 
have not been demonstrated to occur. He tended to favor the view that the 
autonomic neuroeffector formations are plexiform, anastomosing, neuro-
flbrUlar networks that 11e in close proximity to the effector tissues (180). 
This problem reIDI.ins unresolved even tod~y. 
Recently, Kisch h~s reported on some ~tudiee of hum,n he~rts. He 
---. 
26 
demonstrated that the muscle fibers of both the atria and the ventrteles are 
less well supplied by nerve fibers than are the coronary vessels. However, 
by electron microscopy, fine nerve fibers could be found between muscle 
fibers even when no blood vessel was nearby. Axons with fine tapering ex-
tensions were found in contact with the sarcolemma of muscle fibers. Kisch 
cautions, however, that the question of wbether a nerve in contact with the 
sarcolemma of a muscle Is a centrifugal or a centripetal one cannot be de-
cided by electron microscopy (169). 
In a similar study on human hearts reported by Hirsch, it was observed 
that some large and small nerve tl'Wlks entered the myocardium directly, not 
in association with branches of the coronary arteries. These nerves, after 
they have pentrated the myocardium, have Jl scanty perineurium. 'lbe fine 
nerve fibrils in them appeared to extend d1reetly into the contiguous myo-
cardtal tissues (141). 
At the present t1me, therefore, our knowledge of the terminal innervatioa 
of the heart Is very scanty. However, the function of the cardla.c Innervation 
can be studied in various ways. One of these Is by den.nation studies. In 
1897, Hunt reported that removal of the right stellate ganglion in the dog or 
the cat caused a considerable slowhtg of the heart with little effect on the 
blood pressure. Removal of the left stellate ganglion had less effect on the 
heart rate and more effect on the blood pressure (149). This was one of the 
first demonstrations of a functional difference between the right and the left 
cardiac sympathetic nerves. 
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In 1926, Cannon rep)rted experiments in which both the right and left 
vagal cardiac nerves were cut and both stellate ganglia were removed in the 
cat. The adrenal glrulds were also removed and the liver was denervated. 
A cardioacceleration wa.s stUI observed when the cat changed from a resting 
to an active state. It was found that accessory accelerator fibers from the 
upper thoracic ganglia below the stellate \~,I'ere mediating the acceleration. 
Vlhen these were removed, the heart rate remained steady in spite of vigor-
ous activity (43). In 1939, Cannon reported a study in which extr~.cts of 
sympathetically denervated hearts were analyzed by bioasss.y. He t!ould 
find no sympathomimetic ~t1vity In these extracts (44). 
Rub, in 1947, reported a study in which a cardiac sympathectomy was 
performed in cats by removal of the caudal cervical and stellate ganglia along 
with the sy.mpa:thetic trunk down to the eighth rib. The catecholamine content 
of the heart after sympathectomy as dekrmbted by colorimetric analysis was 
reduced 44% from the contrallevel (223). Goodall studied the effect of cardia: 
sympathectomy in sheep. He performed four different types of operation. 1) 
Removal of the right superior and middle cervical ganglia caused an increase 
in the norepinephrine content of the heart. 2) Removal of the left superior 
and middle cervical ganglia had no eff;'ct on the norepinephrine contert of the 
heart. 3) Removal of the right stellate ganglia deerea.sed the norepinephrine 
content of the heart. 4) Removal of the left stellate ganglion had no effect. 
When all four operations Vlere performed on the same animal, the norepineph-
rine content of the heart fell to the same level as it did wh-::n the right stellatf: 
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grotglion alone was removed. Goodall concluded that the right stellate gang-
lion is the ganglion of implrtanoe in controlling the norepinephrine content 
of the sheF'p heart (115). Goodall later continued this study on the sheep and 
also extended it to include the dog. By means of similar experiments, he 
showed that in the dog the right stellate and middle cervical ganglia seemed 
to be most responsible for control of norepinephrine in the heart. In the 
sheep the inferior cervical and upper thoracic ganglia on the right stde seeme 
to have the greatest blfiuence (1, 16), 
Many authors have observed regenel"atlon of sympathetic fIbers following 
a sympathectomy. In 1897, T ...angley reported a study in which the post-gang-
lionic fibers from the superior cervical ganglion were cut in the cat. The 
dilator muscles of the iris, the museles of the orbit, rlnd the erector muscles 
of the hairs were studied. Ten weeks "ltar the opera.tion, function started to 
return and by four months function was normal (182). KUvtngton found that 
complete regeneration of vasoconstrictor fibers following section of the dog 
sciatic nerve required nearly seven months (163). C~nl\()n observed that 
following section of cardiac nerves, function began to return At six weeks. 
He postulated that regeneration of cut cardiae nerves may occur in two montIE 
Goodall observed that six weeks after a cardiac sympathectomy, the norepi-
nephrine content of the heart began to rise and by four months it was at the 
normal level (116). 
In 1957, Murray published 11 report of collateral sprouting in the sympa-
thetic nervous system of the eat. Partial denervation of the superior cervieal 
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gfc,nglion in the C;lt w'{s pedo:rmed by severing one or more of the communi-
cating r~mi from their l'espectiYe thoracb nerves. Subsequently, nerve 
sprouts a,rose from the remainlnglntact pre-gvnglionic fibers and formed 
synapses with ganglion cells which were denervated by the operation. ntis 
resulted in an t1most complete functional recovery of the ganglion even when 
as many as 9<Y!(, of the pre-ganglionic fibers bad been divided. Four weeks 
after the operation, there was complete return of function. In a second series 
of experiments, the post-ganglionic fibers were divided. In the cat, the post-
ganglionic trunk of the superior cervical gangUon is composed of two large 
and one or two smaller fascicles. The two la,rge fascicles were diVided, 
lenvL'lg only about 10% of the post-ganglionic trunk intact. The divided proxi-
mal and distal ends were ligated and separated by a distance of at least one 
cm. Ten weeli:s later, the ftIDction of the nictitating membrane had returned 
to normal. This seemed to be due to colla.teral sprouting of the remaining 
intact post .. g~.:.1.g1ionic fibers rather than to growth of axone :from the site of 
division. In another experiment, the post-gnngl1onie trunk was completely 
divided and the proximal and distal ends ligated and &.eIJa:r~.ted aB before. 
&"timulatlon 0' the cervical trunk ten weeks later produced no response of the 
nicltitating membrAne or the p.tpil (~O6). 
Thus it seems that sympathetic nerve fibers do h8ve p" remnrkable capaci 
ty for regeneration and for colla.teral sprouting. 
-CHAPTER II 
METHODS 
A. Surgical Procedures 
The animals used in this study were mongrel dogs of both sexes. Control 
animals were anesthetized with Nembutal (30 mg/kg). The chest was r2.pidly 
opened by means of a mid-sternal incision and the heart removed as quickly 
as possible. The heart WQS w3.shed free of blood and duplicate tissue samples 
were immedi~.tely taken from the following r!rens: 1) the right atrium, 2) the 
left ntrium. 3) the right ventricub.r free w~ll, 4) the left ventricular free wall 
near the base of the heart, 5) the left ventricular free wall neer the apex of 
the heart, f'nd 6) the interventricular septum. The tissue samples were rapid 
ly frozen by plRcing them on squares of aluminum foU lying on slabs of dry 
ice. The twelve samples from each her.rt were then kept in the frozen state 
until time of the chemical analysts. The n.verage size of the atrial samples 
was approximately 0.5 gms while t.1te a,verage size of the ventricular samples 
was approXimately 1. 6 gms. 
Sham operated animals were prepared and their hearts compared with 
those of control animals. The animals were anesthetized with Nembutal 
(30 mg/kg) and prepared for sterile surgery_ A skin incision was made over 
the second rib on either the right or the left side. The muscles were severed 
the second rib was stripped free of its periosteum, and the rib itself was· 
excised. The surgery was terminated at this point. The muscles were 
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sutured togetbel~ and the skin incision was closed. Three to four days 1a.ter 
these anim.a1s were s~_er1f1.eed in the same nlMllt\)r as described for the con-
trols. 
The majority of the animals in this study underweut a unUateral cerV'ico-
thoracic syrnpat.."1ectorny. The surgery was performed in the S3me manner ft .• 
described lor the sha.m operated anintf!ls. Fbllowhlg rem.oval of tile second 
rib, the pIonr=" w~s pi.reed, gllawing rot excellent view of the stellate gang .. 
lion. This "~'mgl1oll w~s removed Rlo~ with the thort<lcic sympat.'wtte trunk 
down to the T5 ganglion inclusive. T'.ne caudal cerviefl! g~llgl1on ~nd both the 
ventrf~l :md dora?l ~J1sa 8ubcbvla were likewise removed. As ~n nclded pre ... 
c [mUon, the V9gUS nerve w~s severed and a.pprQ:droately ~ one inch segment 
remo·voo III tlle ~..rea of the caudal aervlc~l gangl1on. This "'Tft£ done in order 
to Interrupt any sym}X\thettc ner'ves whose p~thwA.Y to the he~l~ might be by 
V13.y of e~rdiae nerves traveling with the v~s Rerve. Upon completion of the 
surgery I the pleura. WllS sutured together and tile chest: was clos~ ir;., t.lttl 
m'Ulner described nbove. 
Other ~nlmals underwetlt a bU?teral cervleo-thoracic sympathectomy. 
The prooedure deoor1bed ~l>ove was performed on first one sIde and then. the 
other. There was n one to two week interv:ll between the two stages of the 
operation. III order to ~,void the problems involved in maintaining a bilateral-
ly v8.gotomized p.nim~l the vagus nerve w~.s not cut In the second st. of the 
operation. 
The pnlmals were s~cr!f1eed ~t v'Prious periods of time after the &yJl1p:1-
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thectomies were performed and cardbc tissue spmples were t!!lken in the 
mf'nner described previously. On ~pproxim~tely one-hfllf of the unU1\tera.lly 
sympathectomized animals, ? functional study wa.s m8de before sacrifice of 
the animal. For these experiments the anim~ls were anesthetized with 
c(-Chloralose (90 mglkg) and the chest w~s opened by means of 9 mid-sternal 
incision. A unipolar electrode was positioned on the remaining intact stellate 
ganglion and all four chambers of the heart were cannulated. Pressures were 
recorded from the four chambers by means of statham P23Db transducers 
whose output was fed into a Grass polygraph recorder. A Grass Model 85 
stimulator was used to stimulate the stellate ganglion. The stimulus usually 
employed had a duration of 5 mBeC" a frequency of lO per second, and an 
intenSity of 5 volts. After the recordings of the functional response to stellate 
stimulation following unilateral sympathectomy were obtained, the heart was 
removed by quickly severing all connecting vessels. It was immediately 
w~shed free of blood and c»rdiRc tissue s~mples taken as previously descrtbe<l 
.A time period of ~pproxim9tely fifteen to twenty minutes was allowed to lapse 
between the bat stellate stimula.tion and the removal of the heeri to allow time 
for mebbol1sm of any newly rele~sed norepinephrine. 
p 
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B. Chemical Analysis of Cardiac Tissue 
All cardiae tissue samples were analyzed for their content of epinephrine 
and norepinephrine ~ccording to the following procedure. The frozen tissue 
sample W'lS weighed on a Roller-Smith bplance. It was then chopped into .. 
small pieces and plflced in a conlc~lly shaped homogenizing tube together with 
5 ml. of O. 4N perchloric ~cid. The tube was then immersed in ~ conbiner of 
ice water in order to keep the tissue cold during homogenization. A glass 
pestle ~tt~ched to p S~rgent cone drive stirring motor was inserted into the 
tube. The tissue w~s extracted once nnd the homogen~te poured into ~ cen-
trifuge tube plpced in ice wR.ter. In some c~ses it w~s necessary to repeat 
the extrnction with» second 5 ml. of O. 4N perchlorlc pcid. Mter the tissue 
h9d been completely homogenized, the conicpl tube and the glas8 pestle were 
rinsed with 1 to 2 mi. of O.4N perchloric a.cld wh1ch was then added to the 
combined extracts. The homogenate was centrifuged at 40 C. and 3000 rpm 
(1500 g) for 15 minutes. 'lbe supernatant was then pmredoff and frozen over-
night. 
After the tissue extract had thawed the pH was adjusted to approximately 
4. 5 by dropwtse addition of 5N potaSSium carbonate solution. A Beckman pH 
Meter, Model Gt was used to check the pH at thts point. 'lbe potassium per-
chlorate formed was then spun down by centrifugation at 40 C. and 3000 rpm 
(1500 g) for 5 minutes. The volume of the supernatant at thts point was 8 to 
15 mt. To the supernatant was added 10 mI. of O. 2N sodium 9cebte solution 
(pH 8.5) ,,:tnd 4 drops of 0.05% cresol red indle~tor. The pH of this solution 
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wPS ~djusted to ~.pproxim::!tely 8.3 by dropwise ~dd1tion of O. 5N sodium 
hydroxide solution. 'rbe extr~ct wps then ~dded to n previously preppred 
::dumin~ column. 
The columns consisted of gbss tubes 35 cm. in height huving Rn intern81 
dif.!meter of 12 mm. which were constricted at one end to an opening 4 to 5 
mm. in diameter. A glass wool plug had been placed in the narrow opening 
of the tube and one gra.m of alumina was placed into the tube. This alumina 
was then repeatedly washed with O. 2N sodium Rcetate solution until the pH of 
the alumina column was approximately 8. 5. rrhymol bIt1. indicator was added 
to the sodium acetate solution being poured through the columns in order to 
cheek the pH of the washings. To this preppred a1umin~ column was added 
the tissue extract which had been brought to pH 8. 3. 
After the extract had run through the column, the alumin~ was washed by 
addition of 10 ml. of O. 2N sodium f'cetate solution to the column. The fU-
trates were discarded. The cateeholamines were subsequently eluted from 
the alunlina column by addition of 10 mI. of O. 25N acetic acid to the column. 
The elua.te was collected in a test tube Dnd was now ready to be chemically 
analyzed for its content of epinephrine and norepinephrine. 
The eluate WI"S mixed with n stirring rod in order to ensure a unUorm 
distribution of the catecholamines in the eluting solution. A 1 ml. nliquot of 
the eluate was ptpetted into each of five 10 mI. volumetric fiasks. The first 
two allquots were carried through the fiuoreseence reaction. The second two 
allquots served as blanks. The fifth aliquot was used in adjusting the pH of 
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the solution. 
TIle fifth ~1iquot was tre~.ted a.s follows: j mI. of a pHS. 0 aeetste buffer 
ruld 2 drops of O. 1% brom cresol purple were added to the flask containing 
the extract. nle pH was then adjusted to approximately 6.2 by dropwise 
addition of O. 5N sodium hydroxide solution. The a.mount of sodium hydroxide 
added was noted. Nothing further was done with this aliquot. 
The first two al1quots were then treated as follows: 1 mI. of a pH 6.0 
acetate bJffer was added. Then the amount of O. 5N sodium. hydroxide solution 
necessary to bring the pH to approXimately 6.2 was added. Next 0.1 ml. of 
O. 25% potassium ferrieyanlde solution WM added as an oxidizing agent. The 
flasks were stoppered and inverted to mix the contents and the oxidation was 
then ~llowed to proceed for five minutes. A.t the end of this time, 1 ml. of 8. 
freshly prepa.red solution of 9 p~rts 5N sodium hydrOxide solution and 1 part 
2% rs.scorbic acid solution was added. The fiB,sks were ~gn1n inverted to mix 
the contents ~nd ~ period of three minutes ~llowed for development of 
fluorescence. ,At the endol this time the solution w~s diluted to 10 mt. with 
triple distilled water, thoroughly mixed by inverting the fbsk severru tim.es, 
poured Lito 'l g12,~s Cl·vt:;tte, flnd the fluorescence rend. 
The third and fourth aliquots were merely diluted to 10 ml. with triple 
distUled water and the fluorescence read in order to determine how much 
fluorescence was contributed by the cuvette, the water, and the eluate itself. 
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MATER.lALS 
1) Perchloric Acid, 70 - 72%, A. c. S., J. T. Baker Chemical ';ompany 
2) Potassium Carbonate, Crystal, A. C. S., J. T. Baker Chemical Company 
3) Pyrex Wool Filtering Fiber, Owens-Corning Flbergbs Corporation 
4) Alumina, Adsorption, 90 - 200 Mesh, Fisher ~~ient1fic Company 
5) Sodium A,cebte, Grtlnubr, Analytic~l Reagent, M~ninckrodt Chemical 
Works 
6) Cresol Red, Sodium Salt, .Allied Chemical CorJXlration 
7) Thymol Blue, Sodhtm Salt, Allied Chemical Corporation 
8) Sodium Hydroxide, Pellets, A. C. S., J. T. Baker Chemical Company 
9) Glacial Acetic Acid, Reagent, E. L Dupont De Nemours and Company 
10) Brom Cresol Purple, Water Soluble, Chicago Apparatus Company 
11) Potassium Ferricyanide, Crystal. A. C. S., J. T. Baker Chemical ComPll1 
12) l-Ascorbic Acid, Eastman Kodak Company 
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~;. Discussion of Chemlcel Analysts 
The first step in the chemical an~lysls of the content of epInephrine and 
norepinephrine in a tissue is the prepllration of the tissue extr~lct. The three 
agents most commonly used for extr~ctlon sre 1) 9.cid ethnnoi, 2) trichlorace-
tic acid, and 3) perchloric ttcid. When acId eth~nol Is used &.8 the extrtlctblg 
~gent, the eth1mol must be rerooved by evaporation at low temperature and 
low pressure. This often causes 108s of Gl)inephrme and norepinephrine. 
'When trichloracetic acid is used as the extracting agent, it can be removed 
by extraction with dlethyl elber. This also can cause appreciable loss of 
epinephrine and norepinephrine. ParcbIoric acid seems to be the ideal ex-
traction fluid. 111e acid can be neutralized with potassium carbonate. This 
le~ds to the formation of potassium perchlorate, which is only slightly 
soluble in cold water. Moat of the perchlorate is thus preCipitated. The 
method used in this study for the preparation of the tissue extracts is that 
d.escrtbed by Bertler et. at (27). .All steps of the extr~J!Uon were ~a.rr!ed 
out at a tempern.tu:re near 00 C. In fresh tissue extr~ets, ~ fine suspension 
b~ often pref:ent. The extr~.ct w~s pbced L'l R freezer overnIght, ~ccording 
to the method of Bel~t1.er. The folk/wing day this suspension could be easUy 
spun down together with the pot~ssium perchlorate ~fter th9wing AAd neutr31-
iz~tion. 
The next step in the chemical analysIs is purification of the crude extrt;.Ct 
'lbe method of purtflcatkm by adsorption on aluminum oxide was developed by 
Lund (191). For adsorptloD, Lund found that 1 gm. of aluminum oxide was 
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suitable for solutions containing up to 9. few mlerogrsIDs of ca:techolnmtnes. 
Lund !.llso noted t"1ll.t the optimum pH for ndsorption of cttte.:-;hola1llines on 
:duminum oxide is 8.4. BY' flU' the great majority of workers in the field of 
catechol1Ul1ine analysis hJve used the method of adsorption on aluminum 
oxide !is the means of purifying theil' tissu~ extr!l.ct or plasma sample. Most 
workers are very careful to brhlg their satnple to a.pproximately pH 8. 4 
before adding it to the alumina. However a great many Vlorkers make no 
attempt to bring li}e alumina itself to pH 8. 4. 'The alumina as it is purchased 
!rom the ma:aufacturer is usually highly alltaline. Addition 0:£ t11e sample to 
this a.lu:mina without checking its pH could lead to partial destruction of the 
catecho!anlines in tIle s31nple. rome workers recommend acid washing the 
alumina. If this acid ~lashed alumina is then used without checking its pH, 
incomplete 2!lsol·ption of 'tP.e catecholammes could result if the pH of the 
alumhta is below B. 4. So it seems that, whether the alkaline alumina or the 
~lcid washed alumins. is used, adjusting the alumina to the OptilIlUn1 pH is 
eS3entinl for complete adsorption of cateeholanUllGs. 
In thi:; stud.y, the alu;:nim~ was not ~eid VIr-shed. One gram of aUca.line 
nlumill~ "'"'2.S added to r: glass COlUlilll 1::ontail1illg ~~, glEss vlool plug. About 
]0 ml. of O.2M sodium !1cetate solution conbining thymol blue :)8 ~n indicator 
was then a.dded to the alumina in the column. Following the recommendation 
of WeU··Mat'l)erbe (28~), a glass rod W:lS gently worked up mtd down l'1 the 
alumina colum.n to remove any air bubbles and to prevent the alumina from 
clumping. At no time was the alumina column allowed to run dry, since 
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thiS may lead to the formation of ~dr channels through the alumina column. 
The eolumn was repeatedly wa.shed with sodium a.cebte solution containing 
thymol blue unill the pH of the fUtr'ite was g.5 a.S indicated by the colQr. 
'11le tissue extract was ad1usted to pH 8,3 tn the m~mner described in 
the preVious section of tbt.s ch~.pter. After adsorption the column w~.s 
wnBhed with sodium acetnte solution. At no time was the alumina column 
w~.shed with anv thing other than pH 8. 5 sodium acetate solution. Some 
workers l"eeommend that the washing with sodtum _eet~te solution be 
followed by ~ 'F.lshlng with distUled wnter. This reeommend~tion ~B not 
followed for fe1!r tJud some of the ct't4eehobm.fne :rr;ight be lost if the pH of 
the aluminn were to cb~nge from 8. 5, 
Pyrex glus wool W'~s used PS ~ plug ~eeord1ng to the recommend~.tion 
of Ludemann (187). He found that filter p1lper or cotton wa.s unsuitable stnce, 
even after repeated 'W~.shtngs, these subst~nees tended to provide traces of 
fluorescence. A sintered glas6 fUter has been recommended by some work •• 
""00. was tried in this study but it was found tba.t the alumtn~ particles tend to 
clog the filter. Therefore a pyrex glass vlOOl plug seems to provide the best 
fllter. 
The elution of the cn.techolammes from the alumina column was carried 
out by the addit1on. of lO mI. of O.25N a.eetie acid to the column as reeommend 
ed by von Euler (98). The eluate Wtls then ready for the third step in the 
chemical aMlysls, the formation of the fiuol'escent products. 
11181'8 are ba.sically two types of chemical rea.ctions by which epinephrine 
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ruld norepi.~ephrfne c~.n be made to yield fluorescent produotB. One !'·malys!s 
irrrrolves the formation of tri-hydroxy-indole compounds while the other 
analysi.s involves the forillation of ethylene dinmine condensation products. 
The ethylene diarr-..Jne method is performed in the following marulol' (251). 
To the eluate from. tbe uumm{';. column 1s r~d,:1ed etbyle!\G diLmine. This 
m.txtU:re is then he~.ted ~t sOO C. fOl'" 20 minutes .. cooled to room temperature. 
p.nd s~l1;Ul·:lted with saUd sodium cholride. '!be solution is ~cted with 
isobubmol, the isobubmol Inyer removed, tlnd its flUOr6t.JOence reatt The 
condenEJ~t1on re9.ction tp,kes pl~ce it,. aJlt~ .. Hne solution. It is immediPtely 
preceded by ~n oxidfltlon of the epinephrine ~nd l101'epinephrine to their 
corresponding oxtd~t1()n products. According to the ~uthors, the most notftbl 
:t:dnntage of this method is that the unst1'4ble nnd highly re~~tive oxidation 
products ~re tr~pped 1n their nnseent sbte ~nd quantitatively converted to 
completely stable eondenem.tton products. The ethylene diamme oondensation. 
method is less specific than the tri-hydrOXY-indo1e method. Sever~,l catechol 
derivatives other thsn epinephrine and noreptn8Jh~1ne will form condens1ttion 
products with ethylene diamine but wUl not carry oot indole ring closure. 
'lbe trl-bydroxy-indole metbod of analysts of epinephrine lAd nbnptneph 
rine was developed by LUlld (l90). It Involves basically the oxidation of 
epmephrme and norep1llephr1ne, followed by the addition of strong alkal1 to 
produce the fluorescent products. The yellow green ftuoreecenee which 
appears in. solutions of epmephrtne after addition of strong albli was studied. 
by Paget 1ft 1980. G~.m and SchUd in 1934 found tlU.t.t the rea.ction required 
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oxygen. In 1948 the studies of Ehrlenled him to conclude that the formation 
of the fluorescent compound was due to 9 rearrangement of the oxidation 
product. Ehrlen g~ve the correct formula for the fluorescent compound of 
epinephrine as I-methyl-S, 5, 6-tri-hydroxy-indole. Attempts to utilize this 
method for the quant1t~tive estim~t1on of c9techol!lmines were lArgely un-
successful because of the instnbility of the fluorescent compounds. Lund 
demonstrated by oxygen titration that two atoms of oxygen per mole of 
epinephrine are required to produc~ the fluorescing molecule. In excess 
oxygen the fluorescence quickly reaches a maximum and then rapidly dis-
appears. Thus the destruction of the fluorescent molecule also involves an 
oxidation breakdown (131). Ehrlen modUied the chemical analysts by the 
addition of a reducing agent by which further oxidation of the fluorescent 
compound was prevented. In his analysis Ehrlen used potassium ferricyanide 
as the oxidizing agent. Lund adapted the method of Ehrlen and used manga-
nese dioxide as the oxidizing agent. Lund in 1950 was the first to dlfferen~ 
tially determine epinephrine and norepinephrine using the fact that the oxida-
tion of norepinephrine at low pH' 8 proceeds very slowly whU. epinephrine is 
still rapidly oxidized (191). Allla.ter methods for the determination of 
epineJiu'ine and norepinephrine Involving the formatiOft of tri-hydroxy-Indole 
compounds are modUlcations of the method described by Lund in 1950. 
The names given to the oxidation products of epinephrine and norepineph-
rine are adrenochrome and noradrenochrome, respectively, while the 
fluorescent products are named adrenolutine and noradrenolut1ne. The 
,... 
oxidation reaction for epinephrine is as follows: 
HO-O' -~-OH 
HO -, CHa I 
NH 
l 
CHa 
Epinephrine Adrenochrome 
The addition of strong 3lkRli results in the following rearrangement: 
o=O-fH-OH ~ 
0::::: #\ CH2 N1 
I 
CBa 
Adrenochrome 
HO-OI-9i-OH HO- ~ \ CH ~ N' 
\ 
CHa 
Adrenolutine 
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The procedure used by Lund is as follows: the catecholamines are adsorbed 
on aluminum oxide at pH 8.5. After elution with O. 2N acetic aCid, the pH 
of the solution is about 4. Lund states that the difference in oxidizabillty 
between epinephrine and norepinephrine permits the determination of these 
two substances in the same sample. 'lbe epblephrine is oxidized quantita-
tively to adrenochrome within the entire pH range of a to 7. Only 5% of the 
norepinephrine is oxidized to nor adrenochrome at pH 3. 0 and qul'ntitattve 
oxidation ~t pH 6. 5. 'nlerefore, one sample of eluate Is brought to pH 3. 0 
and oxidized. A second 83mple of eluate is brought to pH 6.5 and OXidized. 
Mter rearrfUlgement with strong alkali to the corresponding lut1nes and 
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st~biltzation with ascorbic 3.cid, the fluorescence intensity can be metlsured. 
The difference between the fluorescence in the samples oxidized ~t pH 6.5 
~md at pH 3. 0 makes possible 2 calculrtion of the AlnOUnt of epL"1ephrL'le and 
the amount of norepinephrine in the eluate. 
Von Euler and Floding, in 1955, published 11 modification of the method 
of Lund (85). Potassium ferrieynnide was used as the oxidizing agent rather 
than the manganese dioxide used by Lund. The oxidation was c~rried out at 
pH 6. 0 and at pH 3. 5. The oXidation of norepinephrine tJ: pH 3. 5 is very 
slow. However, the author noted that the oxidation of epinephrine at this 
pH is also slow but could be enhanced by the addition of zinc sulfate. 
'!be method used in the present study for the chemical analysis of 
epinephrine and norepinephrine is based on the method described by von 
Euler :'Ind Floding in 1955. However,~. gre~t tn.'1ny mod1fic~ttons ha.ve been 
introduced. Some of these have been on the '!ldviee of other tnvestig9tors in 
this field ~nd some hRve been !'l result of the per8On91 expertence of this 
writer. Therefore, the chemic::-} ~n"lysis Will now be described in det?il. 
The dlfferentl!? 1 determination of epinephrine and norepinephrine by 
oxidation pt two pH' 8 was checked. It wns found that, in the absence of zinc 
sulfate, the fluorescence of a stnnd~rd norepinephrine solution oxidized at 
pH 3. 5 was approximately 5% of the fluorescence of the same solution oxidize« 
at pH 6. O. The fluorescence of an epinephrine solution oxidized at pH 8. 5 
in the absence of zinc sulfate was approxim~tely 50% of the fluorescence of 
the same solution oxidized at pH 6. O. By the addition of zinc sulfate as a 
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catalyst and lengthening of the period of time allowed for oxidation, it was 
possible to increase the fluorescence of ~n epinephrine solution oxidized at 
pH 3. 5 so that it equ811ed the fluorescence of the same solution oxidized at 
pH 6. O. However, under ident1c~1 conditions, the fluorescence of norepi-
nephrine solution oxidized 9t pH 3.5 was 91so tncre~sed to ppproxim~tely 75% 
of the fluorescence of the spme solution oxidized !!It pH 6. O. 
In a report published by von Euler and Flodlng in 1956 (87), the ~uthors 
recommend the pddition of ethylene ditlmtne tetrr:l-9cetic a.cld (EDTA) to the 
sa.mple. They state, "It has been found essential for the differential estima-
tion of adrenaline and nor~drenaline to ~dd this subsbnce. It has no apparen 
influence on the results of chemical estimation of the total catechols, but its 
presence prevents the often occurring oxidation of noradrenaline at pH 3.5, 
which gives too high a,pparent adrenaline figures". Von Euler also p3tnts 
out that when EDTA is added to the sa.mple, the amount of zinc sulfate must 
be increased 2 to 4 thnes to ensure quantitative oxtd2tion of epinephrine at 
pH 3.5. It was found by this writer that the addition of EDTA did indeed 
decrease the fluorescence of a norepinephrine solution oxidized at pH 3.5. 
However, it also decres.sed the fluorescence of ~n epinephrine solution 
oxidized at pH 3.5. No suibble combination of amounts of zinc sulfate 9.nd 
EDTA was found which would ~llow 100% oxid!)tion of epinephrine 2t pH 3.5 
pnd only 5% oxtd!!ltion of norepinephrine. Therefore it wps decided to c9.rry 
out the Oldd~tion re~ct1on only <:>t the higher pH ~nd to report the results as 
tobl epinephrine plus norepinephrine. 
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According to von Euler, treatment wlth potassium ferricyanide for 2 to 
5 minutes at approximately pH 6 gives maximal fluorimetric readings for 
both epinephrine and norepmephrine (85). The pH should be from 6.0 to 6.5. 
Therefore in this study the sample was titrated to approximately pH 6. 2 and 
the oxidation was carried out with potassium ferrlcyanide for 5 minutes. The 
oxidation was stopped by the addition of ascorbic acid and sodium hydroxide 
solution. 'lbe ascorbic acid and the sodium hydroxide solution must be added 
simultaneously. If the alkali were to be added first, the fluorescent lutines 
formed would be oxidized by the potassium ferrieya.n1de. If the ascorbic 
acid were to be added first, some of the oxidation product may be reduced 
and thus not be converted to the fluorescent lutJnes when the alkali is added. 
Not less than 1 mg. of ascorbic acid must be present in 10 mI. of alkaline 
lutine solution in order to prevent oxidation of the lutines. However, if more 
than 4 mg. of ascorbic acid are present per 10 mI. of solution, the intensity 
of the fluorescence will decrease in proportion to the increasing amounts of 
ascorbic acid (190). In the present study, 2 mg. of ascorbic acid were alwaye 
present in the final 10 ml. ot lutine solution~ 
The fluorescence of the alkaline lutine solutions remains constant for 1 
hour (190). Price and Price (218) have introduced a modification at this 
point of the analysis. Before reading the fluorescence of the lutine soluUons, 
they convert the pH from about pH 13 to approximately pH 5 by the addition 
of 5N acetic acid. 'lb.ls is done in order to reduce the fluorescence of dopa 
and dopamine. These two substances will. be adsorbed on the alumina in the 
46 
same lnanner as epinephrine and norepinephrine. Therefore they wUl be 
present in the eluate in the same amount in which they occurred in the original 
sample. However, with the standard tri-hydroxy-indole analysis, the 
fluorescence produced by these compounds Is very smalL For example, the 
fluorescence intensity of dopamine is less than 1 % of that of epinephrine in 
equimolar solutions. A special modification of the tri-hydroxy-tndole analysis 
is necessary in order to determine these substances (49). Therefore, there 
does not seem to be much advantage to acidtfyfng the lutlne solution in order L 
to reduce the fluorescence contributed by dopa md dopamine. In Addition. 
Pc disadvlntage is that the lutmes are unstable ~t pH 5, so tha.t all readtngs 
of fluorescence must be made at exactly the same time after addition of the 
alkali in order that the percentage of destruction which has taken place will 
be the same for every sample. In the present study the fluorescence of the 
lutlne solutions WfdJ repd at the alkaline pH. 
In the present study, the sample blank., CODBisted of 1 ml. of eluate plus 
g mI. of triple distilled water. 'lbe fluorescence of this sample blank was theD 
subtracted from the fluorescence of the sample. Various authors have 
developed different ways of producing blanks. In the method of Lund, the 
blank Is treated in exactly the same way as the sample except that the ascorbic 
acid is omitted from the sodium hydroxide solution used to produce the 
fluorescent product. The fluorescent lutines formed are therefore oxidized 
and the fluorescence of the lutine solution gradually fades. These are mown 
9.21 "faded blanks". 'lb.e fluorescence of the bbnks 1s not read until 30 minutes 
,I. 
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~fter the ~ddit1on of the .,.rk~1i in order to !:Illow time for the fiuoreseen,"!e to 
r'"'de. Tn the orlgtnrl method of von Euler (85), faded bl}'nks are nlso used. 
Ag~1n ?scorblc D.cid Is omitted from the ~n9Iyste. '1lle blank is re~d " minutes 
nlter the sddltlon of the alk?1i. Von Euler sbtes th~t in the presence of 
ferrlcyantde the fading of the lutines is much more rapid. than with manganese 
dioxide 9S used in the method of Lund. 
In. a later Plbllcatton, von Euler (87) reports a different way of produCing 
blanks. All the reagents are added to the sample with the exeeptJon of the 
ferr1cyanide. Thus no new adrenochrome or noradrenochrome wlll be formed, 
but any adrenochrome or noradrenocbrome already present In the sample wU1 
be rearranged and stabilized as the fiuoreseent luttnes. Price and Price 
slightly modified thts method of producing blanks (218). They add the ascorblc 
acid to the sample ftrst, followed by the ferrtcyanide and then the sodium 
hydroxide. In. this technique, all constituents of the ftnal mb:ture are present 
equally in samples and blanks. 'lbe oxidation of epinephrine and norepllteP1rhl. 
is prevented by the addition of ascorbic acid prior to the addition of ferricy .. 
9nide. Con_quently fluoreseenee does not develop when the mixture is made 
a.J.bline. 
Faded blanks tend to give rpther errs.tic and non ... reproductible fluores-
cence readings. Blanks formed by omitting the pota.ssmm ferrlcy"nlde or by 
adding the ~scorbtc acid before the ferrleyanlde are essentlally identical. 
Both methods measure the fiuorescence due to any adrenochrome or nor ... 
adrenochrome present In the original sample. In this study, when ~~mp!es 
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of elunte were ::ln~lyzed nS bbnks by :lddition of the nscorbic l'lcid before the 
pot~ ssimn ferricyanide, the bbnks alw~ys tended to repd high. If ~ freshly 
m~de solution of epinephrine or norepinephrine were an~lY2'.ed in this mMner, 
the bbnks consistently re ~d low. Tn fF!ct the readings were not sign1fic9ntly 
higher thtm the reading of the triple distilled wpter ~lone. However if the 
solution of epinephrine or norepinephrine were sever~l hours old, the blanks 
tended to rei'td high. This wps most likely due to the f~ct th~t some oxidation 
h"d t~ken pIpee ~nd th.ere w~s some adrenochrome or noradrenochrome 
present in the orfg'.dlal solution. This is probably also the explanation for the 
high reading obtained when samples of the eluate are analyzed as blanks in 
this manner. 
There is ample oPIX>riunity for some oxldatlon to occur during theproce 
of extraction or the catecholamine s from the t12sue sample and the subsequent 
purification of this extract before it 13 ready for chemical analysis. If the 
blank is treated in the way described above, the reading will be hfgh since a 
small amount of the catecholamines origina.lly present m the tissue sample 
wm already have been oxidized to adrenochrome and noradrenochrome. if 
this bJank readlng is subtracted from the sample reading, the resulting 
fluorescence will not give a true indication of the amount of catechola.m1nes 
present In the original tissue sample * A reagent blank containing all of the 
reagents bat no sample has essentially the sam" fluorescence as the triple 
dlst1lled water alone. This indicates that the reagents do not contrlb1b.t any 
fluorescence of themselves. It seems thel4 e that a valid sample blank 
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m"Y be produced by merely diluting ~ s'-'mple of the elu"'te with triple dietnled 
w~ter.. TMs will give ~ vnlue for the "mount of fluorescence contributed by 
the elv.ate, the \V~te:r, ~nd the cuvette. When thie .. e,ding is Sllstracted from 
the sample re~ingJ the resulting fluorescence Is due to the epinephrine and 
norepinephrine present in the ortr1n.al tissue s~mp1e. This 1s the WIJ the 
blanks were produced In the present study. 
Figure 2 
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1he effect of indicators on the final fluorescence of the lutine solution 
was studied. It was found that every indicator tested tended to have a quench-
Ing effect on the fluorescence of the lut1ne solution. Therefore, precautions 
were taken to ensure that no Indteator was present in the final solution whose 
fluorescence was to be reacl. The alumina columns were washed wtth sodium 
acetate solution contatn1ng thymol blue indicator. After the washing, traces 
of thts indicator remained on the alumina.. When added to the alumina column, 
the sImple contained cresol red tndtc~tor. Traces of this indicator also 
remained on the plumina column. However, the column was then w9shed with 
cle9r sodium ~cetate solution which removed al11ndwator from the alumina. 
When the sample WAS eluted with f.\cetic pCid, the resulting eluate was clear. 
In the adjustment of the pH prior to oxidation, no indicator was added to the 
aliquot of eluate to be oxidized. Rf:).ther a sepu-ate aliquot was used which 
was titrated to the proper pH in the presence of an indicator and. then dis-
carded. 
standard solutions of epinephrine and norepinephrine were anal,.ed in 
the same manner as the tissue extract. The pH of the sample wS.s adjusted 
to 8. 3 and the sample was then added to a previously prepared alumina 
column. Following elution with acetic acid, the eluate was analyzed in the 
manner described previously. 'lbese standard solutions were freshly made 
immediately before use and were stable for only a few hours. Standard 
solutions contained 0.10 u gm. (as free base) of epinephrine or norepinephrine 
per mI. in O. 1 N acetic acid. They were prepared from a stock solution 
, 
~ ------------------------------------------------------------~ 
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which conbined 500 u gm. (as free base) of epinephrine or norepinephrine 
per ml. in 0.1 N hydrochlorIc acid. The stock solutions were kept refriger-
ated and were stable for several months. They were prep~red from dry 
I-epinephrine bitartrate and I-norepinephrine bitart:r~te purchased from 
Sigma Chemical Company. 
Recovery studies of epinephrine and norepinephl'ine were made in two 
ways. In the first study, standard solutions of epinephrine and norepinephrb4 
were adsorbed on alumina, eluted, and analyzed. The readings obtained 
Vlere compared with those of standard solutions of epinephrine and norepi-
nephrine which were analyzed without prior adsorption an alumina. The 
average recovery of epinephrine in these experiments was 95% with a range 
from 89 to 99%. The average recovery of norepinephrine was 94% with a 
rmge from 91 to 96%. In the second study, R. st9.ndard solution of norepineph-
rine W9.S pdded to several tissue extracts. The extr~cts were then c~rried 
through the analysis in the usu~l mF'nner. Dupl1c~te tissues were an~lyzed 
without the addition of norepinephrine. The difference in norepinephrine 
concentration between the duplic&te samples was determined, and this value 
was compared with the known Rmount of norepinephrin~ added to the sample. 
In these experiments the aver9.ge recovery of norepinephrine was 94% with a 
range from 90 to 98%. 
All reagents used in this study were prepared with triple distilled water. 
All glassware was soaked in a solution of Alconox detergent, followed by a 
thorough washing with a test-tube brush. It was then rinsed several times in 
-53 
ta.p water, followed by a rinsing in triple distilled wa.ter, 9.00 allowed to air-
drY, inverted. A thorough rinsing is necessary in order that all traces of 
fluorescence introduced by the AlCODOX detergent may be removed. Original-
ly, glassware was cleaned in sulfuric acid-potassium dichromate solution 
and cuvettes were boiled in a. 1:1 mixture of concentrated nitric acid and 
water. However it was found that, with sufficient rinsing, the cleaning pro-
cedure described above with Alconox detergent wa.s equally effective and far 
less cumbersome. 
The instrument used in this study to measure fluorescence was the 
Coleman Modell2 C Electronic Photofluorometer. This same instrument 
hns been used by other tnvestig9tors in this field, e. g., von Euler (87) f,nd 
Sch~epdryver (238). The source of exciting light is a mercury lamp. it 
primary fUter is pbced between the l?mp find the sl.mple. In this study, three 
different primary ftIters were used. 'I'he first primary filter consisted ot a 
Coming 15113 filter In combination with a l:l'lrning '3389 fUter. It trans-
mitted light of a wavelength from 415 mu. to 470 mu. The second primary 
filter was a. Corning #5970 fUter. It transmitted light of a. wavelength from 
320 mu. to 420 lUU. The third primary was a Corning 15874 filter. It trans-
mitted light of a wavelength from 310 mu. to 400 mu. A secondary f1lter is 
placed between the sample and the high vacuum phototube ~ The purpose of 
this filter is fn pa;;4 th~ fl?)oreseent light whUe rejecting the em iting light. 
In this study the secondary filter was a cut-off filter which rejected all light 
of wavelength below 490 mu. The fluorescent light from the sample produces 
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R response ill the high VAcuum phototube whose output is fed through an 
,mpHfier ~nd then into f' Hne~x microammeter h~.v~ !1 100 division seale. 
As !> fluorescence shnd~rd, fI solution of quinine sulfr>te was recommend-
ed by Lund pnd by von Euler. However, this substance was not used in this 
study since it was discovered that the wllvelengths of the exciting and emitting 
light ~re such that the fUter system described 9.bove could not be used. Erne 
recommended the use of a fluorescein solution (69). This was tried in this 
study but was later discarded when it was fOlUld that the fluorescein solution 
tended to fade with aging and could not be stored for any period of time. 
De Schaepdryver recommended the use of a plastic tube, fixed in it photo-
fluorometer cuvette, as a fluorescenee standard. This technique was tried 
and found to gIve reliable results. In this study, therefore, the fluorescence 
standard used was a plastic tube which was fixed in a cuvette. 
The sensitivity of the fluorometer was set with the fluorescence standard 
prior to each reading. standard solutions of epinephrine and norepinephrine 
were not analyzed with each tissue analysis, but were 9nalyzed at various 
perto<is of time throughout this study. 
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Figure 3 
SCHEMATIC OF COLEMAN MODEL l2C ELECTRONIC 
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Calculr·tion of the concentration of epinephrine ?ud norepinephrine in 
el".ch tissue sample wns p'ccomplished in the following manner. Wh~n standard 
solutions containing O. 20 u gm. ep1nephrine or O. 20 u gm. norepinephrine 
were ruu;lyzed ~nd the fluorescence read ~t the three exciting w9velengtbs, 
the following data were obts,med: 
436 rou Hg Une 405 mu IIg line 366 mu Hf.; l:kte 
Epinephrine 48.0 49.0 26.0 
Norepinephrine 14. 0 48.5 26.5 
The values reported represent aet fluorescence, 1. e., the reading of the 
sample minus the reading of the blank. Using these values, the amounts of 
epinepbrine and norepinephrine which would give a full scale deflection 
(100 units) at each w3.velength was calculated. These a.mouDts were a.s 
follows: 
Epine}ilrine 
Norepinephrine 
436 lUU Hg line 405 mu fIg line 366 lUU Hg line 
0.42 u gmt 
1.43 U gIn. 
0.41 U gIn. 
0.41 u gm. 
0.77 u gm. 
O 17£: • tiJ U gm. 
'J'he tissue snmp1es were likewise re::ld pt the three exciting wavelengths. To 
determine the total catecholamine eoncentta.tion in the tissue sample, the net 
fluorescence of tho SSr.lple ~t the 405 mu and the 366 mu wavelengths were 
used. 
Using the 405 readbtg, the calculation is as follows: 
~P..e){!t!i)(O. 41)(1.0) :; concentration total catccholamines 
100 wt. of sample) 
Using the 366 reading, the calculation is as follows: 
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'Ilte factor of lOIs present in the numerator beC~UH only one-tenth of the 
elua.te w~s snalyzed. The fector 100 is present In the denominator becwse 
the amount of cfltechobmhte which would give lOO units of deflection is used 
in the calculation. The reading used in tllese c~lculfttlons 1s the pverRge of 
tbe net fluore scenc 0 of the two aliqnots of eluate which were Fm~lYBed, The 
vRlues obtained from using the 405 re~ding "nd the 366 rep.dtng Agree closely 
and the average of the two 1s taken as the conc9ntration of the total eatechol~ 
amines in the tissue sample. The duplicate tissue sample from the same 
area of the heart 18 analyzed h1 the 88,me manner. The values for concentra-
tion of total catecholamines in the two tissue samples are then aver1!4ged and 
the resulting figure Is reported for the concentratkm of total cateeholamiDes 
in that particular arer. of the heart. 
To differentiate between the amount of epbleptnephrme and the 9mount 
of norepinephrine in the tissue sample, the following c,-lculations were CUTied 
out. First it is assumed that ttl1 of the C Bteeholamme in tbe tissue sample 
Is norepinephrine. The calculation, using the 437 mu reading, Is as follows: 
(Readtng)(1.43)(10) = Concentration norepinephrine 
(100)('it: of samPle) 
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If the value obtained agrees with the value previously calculated for total 
catecholamine, it Is reported as the concentration of noreplneIitrine in the 
tissue sample and the value for epinephrine is reported as zero. If, however, 
the value obtained Is higher than the value previously calculated for total 
cateeholamine, the following calculation is performed. 
The calculation utilizing the 405 and 366 readings bas given a value for 
E + N . The calculaotion utilizing the 436 reading bas given a value for 
IN + 1. 43 E 1. The difference between these two calcubtions, therefore, r O. 42 ~ 
is represented s.s ~ + k g E] _ [E+ NJ or 2. 4E. In other words, the 
difference between the calcula.tion with the 436 reading and the previous 
calculation for total catecholamine gives a. value which is equal to 2.4 times 
the actual amount of epinephrine present in the sample. Therefore, the 
difference between these two calculations is now divided by 2. 4 and the value 
obtained Is reported as the concentration of epinephrine In the tissue sample. 
This value is subtracted from the value previously obtained for the concentra-
tion of total catecholamine to give the value for concentration of noreptnephrln . 
Price and Price have recommended the use of simultaneous equation In 
calculation the amount of epinephrine and of norepinephrine in a sample (218). 
However in this writer's experience, satisfactory results could not be obtained 
with this method of calculation. It seems that perhaps the experimental 
error inherent in the fluorimetrtc analysis of catecholamines is too great to 
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warrant such a precise mathematical analysis of the data. 
'!be maximum fiuorescence emitted by the lutine solution formed with 
epinePlrine 18 at approximately 540 mll, whne the maximum fluorescence 
emitted by the lut1ne solution formed With norepinephrine is at approxtmately 
550 mu (131). The exact wavelengths of maximum fiuorescence depend upon 
the wavelengths of exciting light. 'Ihe most accurate way of analyzing 
epinephrine and norepinephrine is therefore with a spectrophotofiuorometer. 
Then the spectral emisston curves of the samples can be analyzed and com-
pared with the spectral emission curves produced by standard solu~;(~n~ of 
epinephrine and norepinephrine. Since such an instrument was not available 
in this study, the fiuorometer described above was used and the calculations 
were made in the manner described previously. 
CHAPTER. m 
EXPERIMENTAL RESULTS 
The animals used in this study were s3,crificed at various periods of 
time after the initial operation. In nll, n. toW of 64 animals were ::malyzed. 
Of these, eight were control :,Inimals and four were sham operated animals. 
On four of the animrJs :a. bnater~l sympathectomy was performed. TIle re ... 
mRining 52 animals underwent a unil2ter~1 cervieo-thor~.cic sympathectomy. 
These animals were sncrifi!~ed between 2 d~ys and 58 days following the 
initial operation. 
}l~our··chamber pressure recordings were obta.ined for 27 of the unilater~l­
ly sympathectomized anim~ls. These recordings were analyzed and the 
functional data were compared with the chemical data obtained from the cate-
cholamine analysis. At one instance during this study, the samples from 
twelve hearts were lost due to a power faUure in which the freezer went off 
and the frozen heart samples thawed. Functional recordings had previously 
been obtained from four of these twelve hearts. For these particular experi-
ments, therefore, no comparison could be made between functional and 
chemical data. 
A total of twelve tissue samples were analyzed from the majority of the 
hearts tn this study_ Two samples each were taken from l) the right atrium, 
2) the left ~.trtum, 3) the right ventricular free wall, 4) the left ventricular 
free wall near the ~.pex, 5) the left ventricular free wall near the base, and 
Rn 
6) the tnterventrteular septum. On some heArts, only ten samples were 
analyzed, the left ventr1culpr a.pax sample being omitted. 
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The following Is a table of the chemical data obbined from each of the 
68 hearts which were analyzed. The first column gives the area of the heart 
from which the sample was taken. In the second column Is rep.>rted the 
content of catecholamlnes, 1. e., epinephrine plus norepinephrine, reported 
as U gIn per gram of tissue. The third column gives the content 01 epinephrinE 
for each area of the heart; and the fourth column gives the content of nor-
epinephrine, determined as the dUference between columns two and three. 
The values reported in columns two and three were calculated in the manner 
described previously in the chapter on methods. 
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S~mple E+N (~JP:~) E~~~ N .(u_~_~. 
gm gm gm 
!Jog C-l, Control!. "5 Kg. 
RA 1.29 0.00 1. 29 
I.lA 0.72 0.17 0.55 
RV 0.42 0.08 0.34 
(base) LV 0.34 0.04 0.30 
S 0.29 0.03 0.26 
Dog C-2, ControlL~~}~·g. 
P .. A 1. 53 0.00 1. 53 
LA 0.75 0.27 0.48 
R.Y 0.60 O. J 1 0.49 
(base) ltV 0.56 0.14 0.42 
S 0.50 0.07 0.43 
DOl C - 3, Con~ll 13 ~. 
RA. 1. 44 0.08 1. 30 
LA 1. 8B 0.07 1. 75 
RV O. "/7 0.17 (1.80 
(b~se) LV 0.87 0.18 0.69 
S 0.70 0.1& 0.52 
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Dos: C-4, Control! 13 Kg. 
RA 1. 62 0.00 1.62 
LA 1. 40 0.00 1. 40 
RV 0.81 O.~S 0.75 
(b~se) l:V 0.43 0.03 0.40 
S 0.49 O. 1.3 0.36 
Dol C-5, Control! 10 Kg. 
RA 1.24 0.04 1. 20 
LA 1. 22 0.00 1. 22 
RV 0.88 0.00 0.88 
(2peX) LV 0.79 0.00 0.79 
(base) LV 0.84 0.00 0.84 
S 0.90 0.00 0.90 
Do~ C-Sz Control, 10 !I. 
RA 1. 28 0.07 1. 21 
LA 1.44 0.29 1.15 
RV 0.82 0.00 0.82 
(apex) LV O.SO 0.00 0.60 
(base) IJV 0.72 0.00 0.72 
S 0.71 0.00 0.71 
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Dog C-8, Controlz 13 lSi. 
--
RA 0.90 0.01 0.89 
1,1\ 0.76 0.00 0.76 
RV 0.74 0.06 0.68 
(a.pex) LV 0.55 0.00 O.5~ 
(bRSe) I-,V 0.49 O. OJ 0.48 
S 0.72 0.01 0.71 
!JoB C-IO! Control! 8 ~. 
RA 2.15 0.14 2.01 
LA 0.93 0.00 0.93 
RV 1. 21 0.11 1.10 
(apex) LV 1.10 0.01 1.09 
(base) LV 0.74 0.01 0.73 
S 1.00 0.13 0.87 
Dog Sbam-l, Right ~e, __ .~. d~yst. __ !.~ ~. 
R,A 1..30 0.00 1. 30 
l!A 1..58 0.17 -;.41 
RV 0.65 0.04 0.61 
(apex) LV 0.53 0.08 0.45 
(base) LV 0.49 0.08 0.41 
S 0.48 0.04 0.44 
,Qog Sham··2, Right Side, 4 d~ys, 1.2 Kg. 
RA 2.10 0.17 1. 93 
'LA 1.03 0.08 0.95 
flV 0.78 0.(;3 0.75 
(apex) LV 0.48 0.08 0.41 
(bt\se) r.,1 0.43 0.11 0.32 
S 0.70 0.06 0.64 
Dol Sham-al Left Stde! 5 dals. 19 Kg. 
RA 0.70 0.00 O. '70 
LA 0.79 0.00 0.79 
RV 0.59 0.03 0.56 
(apex) LV 0.46 0.04 0.42 
(base) IJV 0.47 0.06 0.4l 
S 0.48 0.03 0.45 
Dog Sham-4, l,eft Side, 5 days! 1,2.5 Kg. 
RA 1. 50 0.00 1. 50 
LA 1t 74 0.17 1. 57 
R.v 0.90 0.04 0.86 
(apex) 1,V 0.45 0.03 0.42 
(base) LV 0.71 0.03 0.68 
S 0.52 0.06 0.46 
~ WD-20, J.Jeft Stellatectomy, 4 days, 11. 5 !I. 
RA 1.04 0.00 1.04 
LA 0.86 0.00 0.86 
RV 0.38 0.00 0.38 
(base) LV 0.18 0.00 0.18 
S 0.28 0.00 0.28 
Do( WD-23! Left Stellatectoml! 2 dals! 9.5 Kg. 
RA 0.89 0.06 0.83 
LA 1. 32 0.17 1.15 
RV 0.36 0.01 0.35 
(apex) LV 0.26 0.00 0.26 
(base) LV 0.26 0.01 0.25 
S 0.21 0.00 G.21 
DOl WD-25,! Left Stellatectom~l 4 daIs! 7 Kg. 
RA 1.30 0.00 1.30 
LA 0.97 0.25 0.72 
RV 0.29 0 .. 08 0.21 
(apex) LV 0.2'7 0.00 0.27 
(base) LV 0.34 0 .. 03 0.31 
S 0.35 0.00 0.35 
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DOl WD-26z Left StellatectomL 3 days! 14 Kg. 
RA 0.82 0.21 0.61 
11,,0\ 0.54 0.17 0.37 
RV 0.27 0.06 0.21 
(~,pex) lV 0.38 0.06 o ~" .... '" 
(base) 1, iT (\.31 0.00 0 .. 31 
S 0.44 0.00 0.44 
Pol WD ... 28l Left stella~tomL 3 dalel 10 g. 
RA 1.02 0 .. 10 0.92 
LA 0.97 0.00 0.97 
BV 0.47 0.04 0.43 
(apex) LV O.~6 O.f'C 0.46 
(base) LV 0.34 0.00 0.34 
S 0.49 0.00 0.49 
J?og APR-29z l~ft ~enateetomII 3 dals, 12 Kg. 
RA 0.93 0 .. 23 C.65 
L.A 0.25 0.13 0.12 
RV 0.49 0.13 0.36 
(~pex) tlV 0.60 0.10 0.50 
(base) ltV 0.55 0.07 0.48 
S 0.38 0.00 0.38 
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DOi APR-31 t I,eft Stelh,teetoml! 3 dazs! 12 Y...g. 
RA 0.54 0.00 0.54 
IJA. 1.00 ~.OO 1. 00 
RV 0.75 0.00 0.75 
(apex) 'LV 0.56 0.11 0.45 
(bilse) I ~, 0.30 0.18 0.17 
S 0.51 0.01 0.50 
~~ APR-34, Left stel1atectoml! 4 days! 11. ~. 
RA 0 .. 90 0.00 0,90 
llA 1427 0,,00 1.27 
RV 0.29 0.01 0 .. 38 
(apex) LV 0.40 0.00 0.40 
(base) LV 0.19 O~ 04 0.15 
S 0.31 0.00 0.31 
;t?2i APR-35, 1,eft Stellatectorny, 4 days, 13 ~. 
RA 1.10 0.07 1.03 
LA 1. 15 0.00 1.15 
RV 0.61 0 .. 00 0.61 
(apex) LV 0.33 0.00 0.38 
(base) LV 0.35 0.00 0.35 
S 0.49 0.04 0.4.5 
r ~-------------------------------------------------
69 
DS!I WD-212 Right stellatectomll 4 dals, 12~. 
RA 0.66 0.00 0.66 
:LA 0.47 0.06 0.41 
RV 0.38 0.00 {l.3S 
(npex) I.V 0.32 0.00 O. ~~ 
(b~se) LV O. :6.9 0.00 O. 19 
S 0.43 0.06 O~S7 
~ WO .. S2! R~t Ste11atectorny. 3 days, 12 !I" .. 
RA 0.'10 0.00 0.70 
I,A 0.88 0.08 0.80 
RV 0.73 0.00 0.73 
(apex) LV 0.58 ·0.00 0.58 
(base) YJV 0.45 0.01 0.44 
S 0.46 0.00 0.46 
~ WD ... 2~ R!et 8teUatecto!!!L 4 dalsa 9.5 ~. 
RA 0.50 0.00 0.60 
LA 1.06 0.25 0.81 
RV 0.36 0.00 0.36 
(apex) LV 0.89 0.00 0.39 
(baM) LV 0.35 0.00 0.35 
S 0.24 ,00 0.24 
,,-. 
~------------------------------------------------
'10 
~WD-2'11 R!&ht SteUateet0!!l! S dals~ 10.5!1. 
RA 1.24 0.00 1.24 
LA 1.77 0.10 1.67 
RV 0.39 0.00 0 .. 39 
(apex) LV 0.43 0.14 0.29 
(base) LV 0 .. 39 0.04 0.35 
S 0.53 0.00 0 .. 53 
Poe WD-29. R!I!!! St.el1~el. 3 dalsi 12. 5 ~ .. 
RA 0 .. 93 0.21 0 .. 72 
LA 1.31 0.28 1 .. 03 
RV 0.87 0 ... 00 o. srI 
(apex) LV 0.70 0.06 0.64 
(base) LV 0.52 0.10 0 .. 42 
S Q 4' . -- 0.04 0.37 
t;!!I APR-aOI RIght 8teUat.toml t 5 d!l!,e 15!1. 
RA 0.18 0 .. 08 0.08 
LA 0.17 0.08 0.09 
ltV 0.25 0.00 0.25 
(aptS) LV 0 .. 27 0.00 0 .. 2'1 
{bue)LV 0.45 0 .. 00 0.45 
8 0.38 0 .. 00 0.38 
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DQS APR--S21 Right steUatectolllY. 3 dlllsi 14~ .. 
RA 0.23 0.17 0.08 
LA 0.49 0.08 0.41 
RV 0.48 0.00 0.48 
(npex) LV 0.33 0.00 0.33 
(b">se) LV 0.32 0.00 0.32 
S 0.39 0.03 0.36 
D9I ~~-38, R!gbt Stelb.tectomy, 3 d~ys,. 1,2 !I. 
RA 0.42 0.04 0.38 
LA 0.67 0.14 0.53 
RV 0.34 0.21 0.13 
(flpeX) LV 0.30 0.11 0.19 
(b?se) LV 0.37 0.04 0.33 
S 0.38 0.07 0.31 
P9I APR-S? Right StellatectomL 3 days, 10 Kg. 
RA 0.46 0.00 0.46 
LA 0.73 0.08 0.67 
RV 0.68 0.03 0.65 
(apex) I .. V 0.48 0.06 0.42 
(base) LV 0.55 0 .. 07 0.48 
S 0.44 0.02 0.42 
~------------------~ ~, 
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Pog ~-13, Left Stellate.ctoml, 7 days, !~Kg. 
RA 0.87 0.08 0.79 
LA 0.96 0.11 0.85 
RV 0.49 0.00 0.49 
(base) LV 0.23 0.00 0.23 
S 0.36 0.00 0.36 
Dos W~-15, l;..!B stenateeto!!!lt 7 daIs. S .. 5 ~. 
RA 1.14 0.03 1.11 
LA 1.08 0.25 0.83 
RV 0.52 0.00 0 .. 52 
(base) LV 0 .. 30 0.00 0.30 
S 0.38 0.00 0 .. 38 
~WD-181 Left steU3teetom.y~da7., ;t4_!.r. 
RA 0.75 0.06 0.69 
LA 0.40 0.00 0.40 
RV 0.39 0.00 0.39 
(.pex) LV 0.31 0.00 0.3l 
{b_)LV 0 .. 31 0.00 0.31 
S 0.33 0.00 0.33 
~~---------------------------------
R'" ;.J ':. 
rA.~ 1.12 0.07 
RV 0.79 0.00 
O)·~};e) 'LV 0.68 0.00 
S 0.54 0.00 
P!!I APR ... 19, Left Stel1~eeto!lY! 7 days, 9 !Yr. 
R.A 0.93 0.18 
LA 0.58 0.08 
RV 0.41 0.00 
(bpse) LV 0.43 0.00 
S 0 .. 41 0.00 
!?!S .~rn-21, Left Stel1~ectomy, 'I d.,ys, 15. ~ ~. 
RA 0.35 0.01 
LA 0.62 0.03 
RV 0.l8 0.00 
(apex) JolY 0.16 0.00 
(base) LV 0.1.3 0.00 
S 0.15 0.03 
1.05 
0.79 
0.53 
0.54 
0.75 
o.so 
0.41 
0.43 
0.41 
0.84 
0.59 
0.1.8 
0.18 
0 .. 18 
0.12 
73 
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D~ APR-t~ Le~ Stellatectoml! 7 daIs! 14 Kg. 
RA 0.83 0.14 0.69 
LA 0.48 0.03 0.45 
RV 0.27 0.00 0.27 
(apex) LV 0.35 0.00 0.35 
(base) LV 0.28 0.00 0.28 
S 0.31 0.00 0.31 
D2I APR-33. Left stellatecto!!lz 6 daIsz 8 Kg. 
RA 0.89 0.27 0.62 
LA 0.7S 0.18 0.55 
RV 0.37 0.00 0.37 
(apex) LV 0.33 0.00 0.33 
(base) LV 0.39 0.00 0.39 
8 0 .. 46 0.00 0.46 
Dqc WD-16. Right stenateetoml! 7 daIs! 13~. 
RA 0.83 0.08 0.75 
LA 1. 38 0.25 1.13 
RV 0.70 0.03 0.67 
(a.pex) LV 0.73 0.00 0.7S 
(base) LV 0.78 0.00 0.78 
S 0.'10 0.00 0.'10 
'15 
!?OiWD-l~t R!sht Stallatectomlz 7 daIs! 10 ~. 
RA 0.7'1 0.17 0.60 
LA 1.76 0.13 1. 63 
RV 0.90 0.04 0.86 
(apex) LV 0.68 0.01 0.67 
(base) LV 0.74 0.01 0.'13 
8 0.66 0.00 0.66 
DQg APR-10. R!(ht 8tellatectomlz '1 daIs. 8. 5 Kg. 
RA 0.32 0.07 0.25 
LA 0.42 0.00 0 .. 42 
RV 0.09 0.00 0.09 
(ppex) LV 0.20 0.00 0.20 
(base) LV 0.19 0.00 0.19 
S o. 18 0.00 0.18 
D!!{ APR-22! Right SteU9tecto.!!l.I, '1 dal~ 5. 5 Kg. 
RA 0.74 0.04 0.70 
LA 0.62 o. : •. 0 \).52 
RV 0.42 0.07 0.35 
(apex) LV 0.43 0.06 0.37 
(base) LV 0.72 0.07 0.65 
S 0.63 0.03 0.60 
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D~ APR-2S! Right Stellatectomy, 7 days! 9. 5 Kg. 
RA 0.99 ~" 0.11 0.88 
LA 0.93 0.08 0.85 
RV 0.19 0.01 0.18 
(apex) LV 0.40 0.00 0.40 
(base) LV 0.58 0.00 0.58 
S 0.49 0.01. 0.48 
~. WD ... 121 Left StellateetomI2 14 days" 11 Kg. 
RA 0.78 0.11 0.85 
LA 0.94 0.11 0.83 
RV 0.29 0.08 0.21 
(base) LV 0.09 0.08 0.01 
S 0.23 0.06 0.17 
Dog APR-17z Left Stellatectomlz 14 daIS! 11 Kg. 
RA 1. 88 0.00 1.66 
LA 1.05 0.29 0.78 
RV 1.08 0.00 1.08 
(base) LV 0.91 0.00 0.91 
S 0.83 0.00 0.83 
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Dog APR-IS, Left Stellateetomlt 16 days! lO.5 Kg. 
RA 1. 38 0.01 1. 37 
LA 1.09 0.27 0.82 
RV 0.57 0.08 0.49 
(base) LV 0.35 0.08 0.27 
S 0.31 0.08 0.23 
Dol WD ... 4a Left stellatectomlz SO dalsl 9 Xc. 
M 1. 65 0.13 1. 52 
LA 1.40 0.31 1.09 
RV 0.48 0.11 0.37 
(base) LV 0.50 0.07 0.43 
S 0.57 0.08 0.49 
D!I APR-l fJ! Left steUatectomy,. 29 dals! 11 Kg. 
RA 2.00 0.00 2.00 
LA 0.56 0.13 0.43 
RV 0.37 0.00 0.37 
(base) LV 0.11 0.00 0.11 
S 0.28 0.00 0.28 
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DOl APR-131 Right Stellateetomy, 14 days! 8.5 Kg. 
RA 0.35 0.22 0.13 
LA 0.48 0.21 0.27 
RV 0.3'1 0.24 0.13 
(base) LV 0.41 0.14 0.27 
S 0.45 0.21 0.24 
Dog APR .. 1~ R!lht stenlltectoml! 14 d9YSe 7 Kg. 
RA 1.80 C.18 1.62 
LA 0.98 0.55 0.43 
RV 0.46 0.14 0.32 
(base) LV 0.36 0.10 0.26 
S 0.28 0.14 0.14 
D2I WD-32 !lEt stellatectomll 33 dalsz 1 0 ~. 
RA 0.66 0.00 0.66 
LA 1.25 0.00 1.25 
RV 0.46 0.00 0.46 
(base) LV 0.36 0.00 0.36 
S 0.40 0.00 0.40 
r 
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DOl APR-15! Right Stellatectomy.z. 29 daIs! 12 Kg. 
RA 0.81 0.00 0.81 
LA 1.14 0.11 1. 03 
RV 0.41 0.00 0.41 
(base) LV 0.80 0.00 0.80 
S 0.38 0.00 0.38 
DogWD-lz Left ste11ateetomy, 41 dals, 9 Kg. 
RA 1. 37 0.29 1.08 
LA 1.02 0.14 0.88 
RV 0.70 0.00 0.70 
(base) LV 0.49 0.00 0.49 
S 0.50 0.03 0.47 
~ 'V'll-7z Left Stellp..tectoml, 51 daIs! 16 Kg. 
B.A 1. 24 0.29 0.95 
LA 2.54 0.13 2.41 
RV 0.73 0.00 0.73 
(base) LV 0.49 0.07 0.42 
B 0.56 0.07 0.49 
Dog APR-II Left stellatectomyz 44 daIs, 11!1. 
RA 1. 25 0.24 
LA 1.98 0.10 
RV 0.7" 0.03 
(b,se) LV 0 •• O.Ot 
S 0.88 O.Ol 
Dog APR-., Left Stenatec~my, 45 daysz } ~ K(. 
RA 1.17 (l.04 
LA 1. 70 0.32 
RV 0.58 0.04 
(base) LV 0.71 0.00 
S 0.58 0.03 
!?oJ ,,~-,~, Rjpt stellRteetoml, 42 days, . "5 Kg. 
RA 1. 37 O. 00 
LA 
RV 
(base) LV 
S 
0.83 
0.53 
0.46 
0.00 
0.01 
0.00 
1.01 
1. 88 
0.68 
0.48 
0.87 
1.13 
1. 38 
0.54 
0.71 
0.55 
1. 37 
0.88 
0.52 
0 .. 46 
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Dog ~-6, Rlg!lt Stellate~tomy~ 42 days, 15 Kg. 
RA t. 69 0.00 1. 69 
LA 1. 36 0.00 1. 36 
RV 1. 63 0.00 1. 63 
(base) LV 0.75 0.00 0.75 
S 0.80 0.00 0.60 
Dol APR-2! Right StellatectomJa 48 days! 10 !I. 
RA 2.01 0.00 2.01 
LA 2.19 0.06 2.13 
RV 1. OS 0.13 0.90 
(base) LV 0.67 0.11 0.56 
S 0.59 0.08 0.51 
Dog APR-al Right stellatectomy! 43 days! 11 !I. 
RA 0.83 0.07 0.76 
LA O.9t 0.1.7 0.74 
RV 0.24 0.00 0.24 
(base) LV 0.98 0.04 0.94 
S 0.48 0.13 0.35 
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Dog APR .. 25, Bilateral, 8 days p?st right and 2 days P,2st left, 9.5 Kg. 
R~ 0.28 0.08 0.20 
LA 0.39 0.01 0.38 
RV 0.35 0.00 0.35 
(apex) LV 0.25 0.00 0.25 
(base) LV 0.24 0.00 0.24 
S 0 .. 21 0.00 0.21 
Dgg APR-SS, SUmral, 16 d,ys post rtgl! ~I\d 2 day. PJ8t left, 10 !I. 
RA 0.37 0.0r. 0.29 
LA :.02 0.25 0.77 
RV 0.45 0.00 0.4!5 
(apex) LV 0.22 0.00 0.22 
(base) LV 0.31 0.00 0.31 
S 0.19 0.00 0.19 
!?21 APR-S?, SUateral,9 days PQst !,,&ht and 2 days post left, 13 I~. 
FU\ 1.41 0.13 1.28 
LA 1.95 0.25 1. 70 
RV 0.67 0.08 0.59 
(apex) LV 0.42 0.00 0.42 
(bal.) LV O.SO 0.00 0 .. 30 
S 0.59 0.03 0.58 
Dog .l\.PR-28~ Bi1~terd, 15 dRYs post r~t llnd 2~ays I:!st let!, 12 !I. 
~ 0.74 0.11 0.63 
LA 
RV 
(2'.pex) LV 
(base) LV 
S 
0.69 
0.32 
0.60 
0.57 
0.68 
0.14 0.55 
0.00 0.32 
0.00 0.60 
0.00 0.57 
0.00 0.66 
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'llle datn. from tile control bearts demonstrete clearly that there is a 
dist1net difference between the catecholamine content of the atria and that 
of the ventricles. Without a single exception, the catecholamine level was 
markedly htgher in the atrium than in the Ipsilateral ventricle. b Inost of 
t."1c hems, the level was higher in the right atrium than in the left, and it 
wa.s also generally higher in t!U! rtght ventricle than In the left. The differ -
enees between right 9nd left r;!triR and between right ~nd left ventricles did 
not prove to be statistically significant. The p value for both comp~l'isons 
was a.pprox1m~tely 0.10. However, the differenee between the combined 
atrla and combined ventricles was statlst1eally significant. 'I1le p value was 
less than O. 00t. 
In L_ data reported for the sham-op.3rated animals, the atrial cate-
cholaulDle level was, in el8ry instance, ~11gher than that of the ipsilateral 
ventricle. An analysi3 of the data from the unUaterally sympathectomized 
animals shows that the level in the atriurtl 'flas higher than that in the ipsi-
lateral ventricle in all rut ] out of 104 comparisons. 
It is evident from a perusal of the preceding table that great variability 
from one animal to another exists In the range of values observed. The 
following table represents an attempt to simplify the data by reporting the 
average values obtained for each group of animals. 
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Table 2 
Averaged Data, 
RA LA RV LVA LVB S 
Controls (8) 1. 46 1.13 0.78 0.64 0.62 0.67 
Sha.m (4) 1.40 1.29 0.73 0.48 0.53 0.55 
2-5 days (9) Lt. 0.90 0.93 0.43 0.41 0.34 0.38 
2-5 days (9) Rt. 0.59 0.84 0.50 0.42 0.40 0.41 
7 days (8) Lt. 0.86 0.70 0.42 0.28 0.34 0.36 
7 days (5) Rt. 0.70 1. 02 0.46 0.49 0.60 0.52 
14-30 days (5) Lt. 1.53 1. 01 0.56 0.39 0.45 
14-33 days (4) Rt. 0.91 0.96 0.43 0.48 0.38 
41 .. 51 days (4) Lt. 1. 26 1.81 0.68 0.55 0.63 
42-43 days (4) Rt. 1. 46 1. 30 0.97 0.73 0.58 
Bllaterals (4) 0.70 1. 01 0.45 0.37 0.36 0.41 
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Values reported are '1 gm of e~teehobmineB (epinephrine plus ROrepl .. 
nelitrtne) per gram of tissue 1ft 1.) the right atrl1uu, 2) the left :ltrium, 3) the 
right ventricle, 4) the left ventricle nenr the ~pext 5) the left ventricle near 
the b~se, pnd 6) the t"1ter"lentrtcular septnm. l\'umbers in ~.rentheses indi-
c~te the number of ~nimf)ls in .!loh group. 'lbe symools Lt. ~nd Rt. indica.te 
whether ~ left ste:lhteetomy or "l' right steIb,tectomy' w~s performed. At 
tbe extreme left of the chArt fs fndfcrted the length of time which Wop8 'llowed. 
to elnpse pfter the tnitiPl oper~t1on before the ~nlm?la were s~.erfflc.d. 
The 1!tlteeholrmine values in the Sh~m-oper9ted animals were not 
stgnlf1crmUy different from those in the control l'J'llmals. 'ntis indicJ.ttes tbat 
the oper~.tion itself h~d no effect on the c~teebolQmin. content of the hem. 
The most DIUked reduction in eateohtlam_ levels oocurncl ill the anJmals 
studied one week or less after the initial operation.. 1a the allimals studied 
at approximately six weeks after the init1al operatiDa, the levell were not 
much different from those in the control animals. 
In order to compare the effect of right sympathectomy wt.tb that of left 
sympatbectomy t Tables 3 and .. were prepared. 'lbe cateeJtolamtae le .... ls 
in the sympathectomized rm1mals were calculated as per cent of levels In 
the COJluol almals. 
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Table 3 
Cateeholamtne Levels Following Left Sympathectomy 
2-5 days 7 days 14-30 days 41-51 days 
RA 62% 52% 105% 86% 
LA 82% 62% 90% 180% 
RV 55% 54% 72% 87% 
LVA 64% 44% 
LVB 55% 55% 63% 90% 
s 57% 54% 68% 94% 
Table 4 
Catecholamine Levels Following Right Symp~thectomy 
2-5 days 7 day. 14-33 days 41 ... 43 days 
RA 40% 48% 62% 100% 
LA '14~ 90% 86% 115% 
RV 64% 60% 55% 124% 
LVA 68% 7'1% 
LVB 65% 97% 80% 118% 
s 61% '/8% 57% 8'1% 
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It can be seen that left sympathectomy decreases the catecholamine 
level throughout the he~rt, the left atrium being the nrea least affected. On 
the other hand, right sympathectomy decreases the level mainly in the right 
atrium and the right ventricle, the left atrium and left ventricle being less 
seriously affected. 
Ta.bles 5 and 6 were prepared in order to compare the chem1cal data 
with the functional data obtained from analysts of the four chamber pressure 
recordings. Column one gives the number of the animal. Column two in-
dieates the length of time which bad elapsed sinee the InttWoperation. In 
eo:umn three, the contractile response of the right atrium is reported as the 
percentage change in the A-wave during stimulation :}.s compared with the 
pre-stimulation value. Immsdiately under the contractUe response Is re-
ported the content of norepinephrine in the right a.trmm calculated as u gm 
per gram of tissue. Column four shows the contractUe response of the right 
ventrtcle, reported as the percentage ehpnge during stimulation. Below the 
contractUe response, the norepinephrine content of the right ventricle is 
given. In column five :.l.re shown the sttme d~b~. for the left ntrium $.I.S are 
shown in eohunn three for the right ptrium. Column six gives the d~ta for 
the left ventricle. In column seven is reported the absolute change in heart 
rate from before stimulation to during stimulation. For animals wn 8, WD 9, 
WD 10 and WD 11, no chemical data was available. 
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nt.bIe 5 
Left Stellatectomy Followed by Right Stellate Stimulation 
Animal Days Plst op. RA RV LA LV Heart Rate 
WD 11 58 -35 + 300 +25 +20 170-240 
WD7 51 +400 +90 +300 ... 15 140-270 
1. 03 0.73 2.45 0.44 
WD8 45 +85 + 135 + 125 + no 190-210 
WDl 41 + 50 + 60 + 15 + 15 130-130 
1. 1. 6 0.70 0.92 0.49 
WD4 31. + 125 -\ 4~ + 1.30 + 25 185-215 
1. 56 0.40 1. 18 0.45 
WD 12 14 + 115 + 200 + 85 + 95 180-250 
0.68 0.23 0.86 0.03 
WD 13 7 +100 + 65 + 27{, + ~5 180-270 
0.81 0.49 0.88 0.23 
WD 15 7 0 + 35 0 0 170-240 
1"l~ 0.52 0.90 0.30 
WD18 7 0 + 60 +20 +35 1.90-240 
0.71 0.39 0.40 0.31 
WD 19 7 + 140 + 70 +25 +75 195-240 
0.79 1. 07 0.68 
WD20 4 +100 0 0 0 210-250 
1. 04 0.38 0.86 0.18 
\VD 23 2 + 50 +1.0 ~·80 0 85-205 
0.85 0.35 1. 20 0.25 
WD 213 4 + 35 +250 + ~O +15 205-240 
1. 30 0.23 0.79 0.32 
WD26 3 -f 25 +70 0 +20 145-180 
O.C7 0.23 0.42 0.31 
WD28 3 -+300 +15 -I- 70 + 15 110-190 
0.95 0.44 0.97 0.34 
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Table 6 
Right stellatectomy Followed by Left Stellate stimulation 
Animal Days p.lst op. RA RV LA IIV Heart Rate 
WD9 49 +115 +180 +150 +30 200-220 
v~'D .& 42 +15 +10 -25 -10 115-140 
1. 37 0.88 0.52 
\VD 6 42 + 30 + 30 +20 +5 170-205 
1.69 1. 63 l.36 0.75 
VJD 3 33 + 100 + 100 +250 + 65 160-210 
0.66 0.46 1.25 0.36 
WD 10 15 -50 +100 -100 +30 190 ... 220 
"~ ... -..... , '6 ;/j~ J} J.. 7 +75 + 100 0 + 20 150-210 
0.77 0.68 1. 20 0.78 
WD17 7 0 + 25 0 + 10 160-160 
0.65 0.87 1.67 0.73 
V/D 21 4 +100 + 10 0 0 165-170 
0.66 0.38 0.43 0 .. 19 
WD22 3 0 0 0 0 160-160 
0.70 0.73 0.82 0.44 
WD24 4 0 +100 +65 + 125 155-190 
0.50 0.36 0.88 0.35 
WD27 3 0 + 225 0 -if- 185 230-240 
1. 24 0.39 1.. 70 0.36 
WD29 +400 + 75 +15 + 45 140-150 
0.78 0.87 1.1.1 C~ 38 
A correlation between the functional response of the animal and the 
cardiac norepinephrine content W9.S not present in every experiment. Many 
of the animals whose hearts were relatively depleted of norepinephrine gave 
good functlonnl responses to stimulation, while other animals whose hearts 
retained significant amowlts of norepinephrine gave a poor response or none 
at all. 
'lbe polygraph records reproduced on the following two pages are four 
chamber pressure recordings obtained from the hearts of open-chested 
mongrel dogs in which eIther the right or the left stellate ganglion was 
stimulated. Figure 41s a record from a control non-sympathectomized 
animal in which the left stellate ganglion wu stimulated. The trac ings 
show an immediate and profound incre~se in pressures recorded from all 
four chambers. 'Ibis record f.s typical of the response of the control dog to 
left stellate stimulation. Figure 5 represents the response of a control 
non-symp:.theetomized Mimal to stimulation of the right stellate ganglion. 
Accelerption of the heart rate wo:~s more prominent and the left ventricular 
pressure elevation was less ma.rked during It right stellate stimulation than 
with Btbnulatton of the left stellate ganglion. In this figure the mean 
pressures were recorded alternately with the pulsatUe pressures. Figures 
6, 7 t and 8 are from animals which have undergone a unUateral sympathec-
tomy. Figure 6 shows the pressure recordings from a dog on which a right 
stellatectomy had been performed 49 days p.reYiously CAnimal:INID-9). 
Mean pressures in the four chambers were recorded alternately with the full 
9') 
" 
pressure pulses. At the signal, the intact left stellate ganglion was stimu-
lated. The overall response was quite similar to the response observed in 
control non-sympathectomized dogs. The recordings show ~. prompt in-
crease in presrure in aU four chambers. There was also a slight increase 
in heart rate. 
Figure 7 Is a four chamber pressure recording from a dog which had 
undergone ~ right stelbtectomy 15 daya previously (Antmal fAVD-l0). At 
the sign~l the intact left stellate ganglion WtUJ stimulated as above. In this 
1,tnim~l, however, the resJX)ruJes were quite different. The right atriu"ll 
showed rln ~ugmentat1on of the A·-wn.ve with little change in the me"n pressure 
The right ventricle wns strongly augmented. The left ntrium sbowed 3. de-
pression with 9. bll in mann pressure. 1l'J. the left ventricle there V:'~S 
practically no angmentd1on. The respan,*, of this he~.rt to stellate stimu-
lrtlon was definitely abnorm~l. 
Figure 8 shows the four chnmber pressure recordings from a dog on 
which a left stellatectomy had been performed 14 days previously (Animal 
#WD-12). The fast records were taken at 10 times the speed of the slow 
records. .At the signal the intact right stellate ganglion WI3 stimulr.ted. The 
most noticeable chara.cteristic of this record is the very slow onset of the 
response to stellate stimulation. There was eventually an augmentation in 
all four chambers but it began late 9lld developed very gradually. 'This is 
definitely an abnormal response to stellate stimnl:.ltion. 
93 
10-
0-
~ 
70-
lO_ 
t!) I. 
:I: 0 
~ 
::!: 10-
200-
100-
.O~". 
Fif?,1U' e 4 
93 2 
'00 
-& .... --.. I~--
FigUre 5 
PlgUre ·8 
,---. 
10· 
00-
40-
._---------
RT. 
VENT. 
aTI •. LT . ITILLAf. 
(10 C ... ........ C .. .. V) __ 
10- .1'-__ •• " 
mm. H~ 
0-
mrn.H, 
OT . 
ATRIUM 
OT . 
VIE NT. 
'": a...-I 
.. 
LT. 
ATRIUM 
.: 
LT. 
VIE III T. 
"":I"!"'f so_ -
0: :::--
LT . 
ATRIUM 
LT. 
OT . 
ATft, UM 
LT. 
VIE N T. 
u " . 
I ITia. LT . • TILLAr. 
u ••.• · •..•••• e .. • "1 
IT.M . IT . I,.ILLA" 
, .. , ............. '''' 
94 
. '~ tr\.! l 
~ . :- ':;\ ~ .-
2 \_r .• ~~ ~· 
• 3 
4 
. 1 
95 
The recorda shown in figures 7 ~nd 8 ore by no me~ns typlc~l of 
animals who have undergone either D, right or 8, left cudb!!c sympathectomy. 
The responses observed 3re extremely v~rinble from animnl to ;mimr 1. 
An individual f'nalysis of the funct1on~l records reveals the follo'\\1ng in-
formation: 
A. stimulation of the right stellate ganglion in animals which had previously 
undergone a left stellatectomy. 
WD 11 - 'lbe responses to stimulation were lmmed1ate lilt lasted only a few 
seconds in all chambers except tlle right ventricle. In the other three 
cbambers the resPlnses disappeared even tbough the stimulus was stUI 
being applied. 
V-lD 7 - The responses to stimulation were immediate and returned to control 
levels approximately 50 ;:;econds after cessation of the stimulation. The 
left ventricle responded with a depression in a,mplttude of contraction. 
'\vn 8 ,. 'TIle resPlllSGs to stimul~tion were immediate. However, they 
ceased abruptly when the stimulation was ended. There waS no gradual re-
turn to control levels. 
\YD 1 ,. The rtlspooBes to stimubtion developed slowly ~md required 25 
seconds to ntt",in their maximum. The responses observed were sm~' 11. 
\VD 4 - The responses to stimulation required 35 seconds to reach their 
m~xima1 level. In the left ventricle there was an inittal depression in 
systolic pressure. 
WD 12 - The resp>nses obtained were good but re~,~d 30 seconds to 
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rench their m;uci::num. 
WD !3 .. Tbe responscfj were good but developed gradually and required 30 
seconds to ~tt~ln maxb'mm v:11ues. 
WD 15 - 0nl;r the right ve!ltr icle responded and its response was delayed 15 
seconds ~ter the beginning of stll!vJlation. 
ViD !3 .. 1b.e responses were small and were delayed 25 seconds after the 
beginning of stimulation. 
WI) 1~ ~ The responi3es were i;:rr:medi:~te an;:! '?lell developed. 
\VD 20 - Only the right ventricle r~..1Bponded. 
WD 23 - No response occurred ill the left ventricle. Tue resrnnses in the 
other chambers were iIn ... 'nediate. The left ntrium respoaded with R, 
depression L'1 sysu>1ic pressure. 
"T.fD 2~ - The reGponses developed graduslly over 15 seconds. 
VIn 25 ... Only the right ventricle responded well. 
'9!D 2e - The res}X)naes were good nnd ~,tbined thei!' mmmum in 10 seconds. 
p.'. Stlmulntion of tJle left stellate ganglion in antmf'ls which had previously 
undergone ~ right stelbtectomy. 
WD 9 - The responses were good and looked much like those obt~tned from 
fJ! non-sympathectomized animal. 
'wn 2 - 'nle responses were very amall and r4lqrdNd 20 seconds to rep..ch 
their m~!ximum. Tbe response in the left ~trium and ventricle was a de-
preSSion in systolic pressure. 
WD 6- The responses were immediate but small ami luted only a few secoads 
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even though the stinlulus was still being ~ppl1ed. 
WD 3 - The responses were good but required 20 seconds to relJi1h their 
maximum. The return to control conditions raquired over 1 1/~~ minutes. 
WD 10 ... The response in bottl atria wns n depression in systolic pressure. 
Return to control conditions m the ventricles was slow. 
WD 16 - The attainment of m~lmum reaponse required n.~rly 1 minute. 
The retum to control condItions took more than a mimlte. 
WD 17 - The responses were very sm:;U but developed lmm.edi~,tely. 
WD 21. - Only the right ntrmm g~ve A good response. 
WD 22 ... There wns no response nt all. 
\VD 24 .. T'he responses required 30 seconds to reach maxtmllm. Return to 
control required more than a minute. 
WD 27 - Neither atrium responded. The responses in the Tentrtcles were 
good and cieve10ped immediately. 
WD 29 .. Good 1'"esplnses developed promptly in every chamber. The return 
to control conditions required 1 1/2 minu.tes. 
CHAPTER IV 
GENERAl. nISC1JSSION 
The heart is supplied with sympathetic nerve fibers from both the right 
and the left sympathetic trunks by way of the correspondtng stellate and 
caudal cervtcal ganglia. It has been suggested that the right cervieo~· 
thorac 1e trunk funlishes the primary sympathetic innerva.tion of the right 
heart while the left symp1'.thettcs supply m.t!tinly the left heart. This relation-
ship was suggested in 1902 by von Schumacher in a report of a series of 
dissection studies (244). 
The m~ss of functional data reported on stimulation of the right and the 
left sympn.tMt· ; nerve supplies Riso seems to Indicate a difference in the 
distrlbltion to th.e heart from the right sympathetic trunk as compared with 
the distribution from the left sympathetie trunk. The effect on the heart 
rate is, on the a,verage, more pronounced with 2 rigbt sympathetic stimula-
tion than with a left, while the effect on ventricular contraction Is more 
prominent with a left sympathet1e stimulation. This distinction is by no 
means absolute and there is considerable variation from animal to animal. 
This variability in response between animals is evident also in studies 
on unllaterally sympathectom1zed animals and makes a preCise analysis of 
the data somewhat difficult. There is no particular pattern which can be set 
down as the "typical" response of animals with a right or a left cardiac 
sympathectomy. However. :In nearly every experiment, the response of the 
98 
99 
animal can be designated as abnormal when analyzed in light of the average 
response usually obtained in the control, non-sympathectomized :mlm;:tl. 
In an open-chested, non-sympnthectomlzed ",nlmal, stimulation of the left 
stellate ganglion produces nn immediate :;1nd profound elevption of intrr·-
ventricular pressures ~nd of atrial pressures as well. There Is also a 
slight inerease in heart rate. The response Is maintRtned during the course 
of the stimulation and gradually returns to eontrollevels after the stimulus 
is removed. 
If the sameprocedure is followed with 1m animal which has previously 
undergone a right cardiac sympathectomy, a. different response is obts.ined. 
The most frequently seen deviation from the normal response pattern is an 
abnormally long delay in the attaJ.nment of the maximum response to stimula-
tion. Instead of the prompt rise in pressure observed in the control animal, 
there is a slow :md gradual increa.se In pressure which mayor may not 
reach a level comparable to that observed in the non-sympatheetomized 
animal. Such a delay can be demonstrated in the majority of experiments 
on unUaterally sympathectomlzed animals. 
Another deviation frequently seen Is pn abnormally long period of time 
after cessation of the stimulation before the response returns to control 
levels. The response sometimes rempms ':It its maximum VAlue for approxi-
mately 80 seconds after the stimulus is removed before it begins to decline 
flnd then gradually returns to control levels. 
In a few experiments, ~n animal with a. left cardiac sympathectomy 
/~: .... -:--:-» 
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showed essentially no response nt ::lllin the left atrium 9nd ventricle and a 
relatively normal response in the right atrhun and "ventricle. And, vice 
versa, an animal having a right cardiac sympathectomy sometimes showed 
no response ill the right atriunl and ventricle. This would seem to indicate 
that, in these animals, removal of the left sympathetic supply denervated 
the left side of the heart whUa removal of the right bym~thet1c supply de-
nervated the right side of the heart. These results would be in accord with 
the relationship suggested by von Schumacher. 
However, in l1UU1Y of the experiments it unilateral sympathectomy altered 
the response to stellate stimulation in all four chambers of the heart. Many 
vsriations in resJ:Qnse could be noted. The responses in all four chambers 
lll~Y be equnr depressed or they ID;lY be much more depressed on the 
ipsilateral side. ..And in some cr-tse$ the grer'tef~t depressIon of resJX)nse 
w~s seen on the side of the he9"rt opposite to the side of the denervation. 
'rhese experiments indlcnte thft the entire he~rt is suppUed with sy:nlp::lthetic 
fibers from both the ri.ght ~nd the left side. There seems however to be ~ 
great amount of variation from ~l'ltmal to animal. 
A similar v:u-labll1ty between :utimals was noted when the results of 
the chemical analyses were studied. A statistical analysts was applied to 
the data obtained from tlle chemical determinations. The standard deviation 
for each group was calcubted and the v91ues obtained are reported in Table 
7. The values reported are u gm of catecholamlnes per gram of tissue. 
The numbers in parentheses :Indicate the standard deviation. 
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Table 7 
RA LA RV LVA !LVB S 
Controls 1.46 1.13 0.78 0.64 '0.62 0.67 (0.33) (0.40) (0.23) (0.25) (,0.20) (0.23) 
Sham 1.40 1.29 0.73 0.43 '0.53 0.55 (0.57) (0.45) (0.14) (0.02) ~:0.13) (0.10) 
2 .. 5 Days Lt. 0.90 0.93 0.43 0.41 :0.34 0.38 (0.21) (0.33) (0.16) (0.12) (:0.11) (0.11) 
2-5 Days Rt. 0.59 0.84 0.50 0.42 :0.40 0.41 
(0.34) (0.49) (0.21) (0.15) (:0.11) (0.08) 
7 Days Lt. 0.86 0.70 0.42 0.28 :0.34 0.36 (0.24) (0.53) (0.18) (0.08) (0.16) (0.11) 
7 Days Rt. 0.70 1.02 0.46 0.49 0.60 0.52 (0.25) (0.55) (0.34) (0.22) ~:O. 24) (0. 21) 
2-4 Wks. Lt. 1. 53 1. 01 0.56 0.S9 0.45 (0.46) (0.30) (0.31) ~:O. 30) (0.20) 
2-4 Wks. Rt. 0.91 0.96 0.43 0.48 0.38 (0.62) (0.33) (0.06) ~:O. 22) (0.08) 
6-7 Wks. Lt. 1. 26 1.81 0.68 0.55 0.63 (0.08) (0.63) (0.06) ~:0.10) (0.16) 
, 
6-7 WIts. Rt. 1.46 1.30 0.97 0.73 0.58 (0.50) (0.60) (0.69) ~;0.18) (0. 15) 
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'lbe high standard deviation values indicate the large range in the data 
for anyone group_ In order to determine whether the difference between 
various groups are Significant, the p-values were calculated. In each ease, 
the catecholamine level of the control group was compared with the cate-
cholamine level of the experimental group. Table 8 reports the p-values 
which were obtained. 
Table 8 
Control VS. RA LA RV LVA LVB S 
1.) Sham .9OO<p • 500cp<. 600 • 600:p~ 700 • 050(p<. 100 • 300(IX. 400 • 3OO<p<. 400 
2.) 2-5 days Lt. p<.. 001*. 200<jk. 300 • OOhp (. 005* • 001 (p(. ooS* • OOl.;p<.005* • oohp<. 005* 
3. ) 2-5 days Rt. p\. 001* .. 200~p<. 300 • 01 (kp(. 020* • 010(p~. 020* • 010~. 020* • 0(;5<p<. 01 0* 
4. ) 7 days l,t. p<. 001* • OSO<p(. 100 • 001 (~. 005* pc.. 001* • 005 <Pt. 010* • 005(.})<. 010* 
5. ) 7 days Rt. p(. 001*. 600~(. 700 • 050ql(. 100 • l00tp<. 200 .900<p • 100<p<. 200 
6. ) 2-4 wits. Lt. • 700<p(. 800 • 500~(. 600 · 1OO<p<. 200 • loo<p<. 200 • l00<p<. 200 
7. ) 2-4 wits. Rt. . 05~p(. 100 • 400<p<.. 500 • 010<p<. 020* • 200cPc. 300 • 020\}l(. 050* 
8. ) 6-7 wks. Lt. • 200<p<. 300 (control) · 400(1'<. 500 • 500<p<.. 600 • 700(~. 800 
9.) 6-7 wits. Rt. (control) (control) .. 400<J)co 500 • 300<p(0 400 • 500~. 600 
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In three cases, the ca.techolr-un."i.ne level of the experimental group wa,B 
equal to that of the control group_ Therefore, no p-value was entered and 
these three groups are considered as having returned to their control levels. 
The experimental grollPS in which L'le c~,techolamine depletion is 
significant at L'le O. 05 level are Indicated by asterL~S in the preceding table. 
A study of this table reveals that the catecholamine values In the sham .. 
operated animals were not Significantly different from the values found in 
control animals. It therefore can be assumed that the operation itself does 
not cause any change in the catecholam.lne content of the heart. The decrease 
in catecholamine levels observed m the operated animals is believed to re-
sult directly from sympathetic denervatton of the heart. 
In the animals which were studied? to 5 dJ3Ys after the sympathectomy, 
there was 9. s1gn1fic~nt reduction in the catecholamine content of every 
portion of the heart except the left ~tr1um. 'Ibis was true regardless of the 
side on which the operation was performed. Both the right and the left 
sympathectomy caused a signU1cant depletion of catecholamines. 
'lbe group of animals which were studied 7 days after the symp"thectomy 
demonstrated. that there was st1l1ll significant depletion of catecholamlnes In 
the right atrium. 
'lbe animals which had undergone a left sympathectomy had a significant 
reduction In the catechola.m.tne content of the two ventricles and of the 
septum. However, in the animals in which the operation was performed on 
the right Side, the ventricular levels were not significantly reduced from 
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control levels. 
'lbe anlmals whleh were studied 2 to 4 weeks after receiving a left 
cardiac sympathectomy had catecholamine levels which were not signifi-
c antly reduced from those in control animals. In the an1m~18 studied 2 to 
4 weeks After receiving a right ca.rdlac sympathectomy, the depletion of 
catecbobmines in the right atrium wss of borderline significance, while 
there was A 81gnific~nt reduction of ca.te~holRrr..ines in the right ventrie!e 
~.nd in the septum. The left atrium ~nd left ventricle werertot significantly 
alfeeted. 
In the group of animals which were studied 6 to i7 weeks after the 
SYIDllathectomy, there was no longer any significant reduction in the cate-
cholamine level in any portion of tile heart. 
From a study of Table 8 as well as the catecholamine values from 
various portions of the heart in individual experlments as reported In the 
previous chapter, it can be shown that the left atrium is very seldom 
signUlcantly affected by the sympathectomy. 'Ibis is true for either a. right 
or n left sympathectomy. ."nd yet the control catecholamine level of the 
left atrium is not low. On the contrary, it is usually much higher than the 
level In ,1ther ventrlele. However this level seems to remain high following 
3. sympathectomy. The high concentration of catecholamines in ~trial tissue 
suggests tit profuse distribution of sympathetic fibers to this region of the 
heart. And yet sympathetic cardiae den.rv~tion seems to affect neither the 
content of catecholamine in the left atrium nor the functional response of the 
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left atrium to stellate stimulation. When the stellate ganglion is electrically 
stimulated, the left atrium responds with an augmentation in force of con-
traction whkb is recorded as an elevation of the A-wave in the atrial pres-
sure recording. In the majority of the functional experiments ~rformed 
on animals with a WlUateral cardiac sympathectomy t the response of the 
left atrium to stellate stimulation Is essentially the same as the response 
in a normal animAl. At present there seems to be no obvious explanation 
for this aPr1a.rent paradox. It would seem th~t removal of one-half of the 
syrnpatbetic supply to the henrt should s1gnificnntly reduce the catecholamine 
content lmd the functlond response of the left ptrium. .And yet it ap:pe~rs 
th~t remov?l of neither the right nor the left sympathetic supply produces 
this result. 
Another point Ulustrated by the table of p-vnl-ues is that removd of the 
lett sympathetic nerve supply seems to afie0t the entire heart with the ex-
ception of the left atriuln. However, ramov?l of the right sympathetic 
supply seems to affect lnainly tl",e right atriU!A, the l'ight ventricle, and the 
.:~epturn with a lesser effect on the left ventricle and very little \)r no !\ffect 
on the le}~ atrium. Consider, for exam.ple, the animals studied 2 to 5 weeks 
after a right sympathectomy. The eatecholamhte depletion in the right 
atriuln is of border line significance while the depletion in the right ventricle 
and the septum 1s Signifie'':lt. There is no significant reduction in the cate-
cholamine level of either the left atrium or the left ventricle. 
This point Is further illustrated by the following four tables. Tables 9 
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and 10 indicate the average catecholamine values in groups of sympathec-
tomized animals calculated as percentages of the average values for the 
control group. 
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Table 9 
Catecholamine Levels Following l.eft Sympathectomy 
2-5 days '1 days 2-4 weeks 6-7 weeks 
RA 62% 52% 105% 86% 
LA 82% 62% 90% 106% 
RV 55% 54% 72% 87% 
LVA 640'!" Iv 44% 
LVB 55% 55% 63% 90% 
s 57% 54% 68% 94% 
Table 10 
Catecholamine Levels Following Right Sympathectomy 
2-5 days 7 days 2-4 weeks 6-7 weeks 
RA 400~i 48% 62% 100% 
LA 74% 90% 85% 115% 
RV 64% 60% 55% 124% 
LVA 66% 7'1% 
LVB 65% 97% 80% 118% 
s 61% 78% 57% 87% 
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If one considers the animals studied 7 d~ys 1:1fter the sYlnpathectomy, 
it can be seen from Tn bles 9 and 10, that left sympathectomy caused a 
reduction in c atecho lamine content in all areas of the heart, the left atrium 
being le~st affected. However, a right sympathectomy caused a depletion 
of cateeholamines mainly in the right atrium and the right ventricle. 
Tables 11 and 12 give the percentage of samples in each group which 
showed 9 reduction of catecholamines to A.level which WaS less than 2/3 
of the a.v.rage level of the control group. 
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Table 11 
After a Left Sympathectomy 
2-5 days 7 days ~-4weeks 6-7 weeks 
RA 56% 86% 20% 0% 
LA 22% 63% 20% 0% 
RV 78% 75% 60% 0% 
LVA 63% 100% 
LVB 89% 75% 60% 0% 
S 67% 75% 60% 0% 
Table 12 
. .After ~ Right Symp1tthectomy 
2-5 dAYS 7 d~ys ~-4. WHlr-s 6-7 weeks 
RA 89% 80% 75% 25% 
LA 56% 40% 25% 0% 
RV 67% 60% 100% 33% 
LVA 56% 40% 
LVB 56% 20% 50% 0% 
s 78% 20% 75% 0% 
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A comparlson of the effects of a left vs. :. right sympathectomy shows 
that a left sym~thectomy most often caused a reduotion ttl U.le c ~teoholamine 
levels of all a.reas of the heart except the left atrium. However D, right 
sympathectomy most often c~:tlaed a reduotion in the catecholamine levels 
of the right atrium, the rjght ventricle, and the septum whUe it less fre-
quently affected the left atrium md the left ventricle. 
'!bese results then lead to the conclusion that the left sympathetic nerve 
supply to the heart must be rather evenly distributed throughout the entire 
heart, since removal of this innervation seems to affect the entire heart. 
On the other hand the right sympa.thetic supply seems to serve predominantly 
the right side of the he~"lrt witt. 8. lesser amount going to the left side of the 
heart. 1hus when the right supply is removed, the right stde of the heart 
18 more severely affected than the left side. As was stated before, there 
does not appear to be any suitable explanation for the fact that the left 
atrium Is seldom affected by removal of either the right or the left nerve 
supply. 
All of the tables presented 80 far In thts cha.pter haft clearly Ulustrated 
the faot that the c atecho}a,mine level in all • .reaS of the heart Is at its lowest 
value in the animals studied one week or less alter the sympathectomy. In 
the animals studied at a longer interval atter the operation, the levels tend 
to be somewhat higher. In fact, in the animals studied approximately 6 
weeks after the sympathectomy, the catecholamine levels In the various 
regions of the heart are not significantly dUferent from the corresponding 
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levels In the control group of R.nimals. In an attempt to explain this inerease 
in cateeholan1ine levels to neB.r normal v'!lues, it was theori2'~d that s. re-
jnnervatton of the heart ma.y have occurred. 
In the animals studied 6 weeks after the sympathectomy, the functional 
response of the heart also resembles the response in the normal animal. 
The recording obtain from ~n1mal WD 9, which was reproduced in the pre-
ceding cha.pter, could h&ve come from '1 normal animal. Actually the 
?nim~l had tmdergone 1\ unibteral c~rdi~c sympa.thectomy {) weeks pre-
viously. In an pttempt to explein this response, it was aga.1n theorized that 
perhaps the heart has been reinnervnted. 
It remains to be explained, however, just how this reinnervptton may 
take place. The caudal cervical, the stellate, and the first four thoracic 
ganglia of the sympatheettc trunk have been removed on the side of the 
operation. It is possible for the pre-gangliontc sympathetle fibers originat-
Ing within the spinal cord to undergo regeaeratton after they have been cut. 
In all probability, thls takes place in these animals after the operation. 
However, even though a marked regeneration of pre-gangltonic fibers may 
oecur, this could not accomplish much toward rebmervation of the heart 
sinee the post-ganglionic cell bodies have been removed and there remain 
no post-gangUonic neurons with whtch the pre-gangUonic fibers may synapse. 
A second possible means of reinnervation of the heart would be by way 
of post-gangltontc sympathetic neurons originating in the upper cervical or 
the lower tl1or~ctc ('1'5 ~nrl below) sympMhetfe g~ngl1q which remain intact 
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after the operation. It may be possible for th ... fibers to reacb the beart. 
HoweYer it does not seem likely th?t any Bigntflc~nt rein!'ler: :,~ion of the 
heart could occur by this means. And :Indeed, upon post-mortem examina-
tion, there was never found to be an intact nervous connection between the 
regenerating ends of the cut sympathetic trunk and the heart. 
However, a third means exists by which retnnervattoa of the heart may 
occur. 'lbe phenomenon of collateral sprouting in poat-gang11oJ1tc sympa-
thetic neurOllS has been demonstrated by Murray (206). It had previously 
been shown that collateral sprout1Dg occurs In pre ... gantltonie sympathetic 
neurGftS and, 111 1957, Murray demonstrated that this phea.omeaon ean take 
place In post .. gangllon1.c sympathetic n'anrons as well. Murray performed 
his experiments with the post-galllllonlc fibers from the superior cervical 
ganglion. He cut 90% of the post-pagl1on1c sympathetic truD.k, ligated the 
proximal and d18tal ends, _d separated them to prevent them from. rejoin-
ing. In ten weeks, there had been sufficient conateral ..-ting of the 1"8-
m~lnlng Intact post-ganglionic fiber. to restor. normal flmetton to the 
nictitating membrane\ 
Perhaps this may be taking place In the hearts under study in the pre-
sent experiments. When a portton of the sympathetic post-ganglionic -PM' 
to the heart is removed, the remaming poBt-gangUonle fibers which 
originate from the opposite SYlUptthetle trunk may undergo conateral 
sprouting to rehmervate the heart. This is p)stu.lated as an explanation 
for the fact that the catecholamine contAltnt and the functional response of 
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the heart begin to return to normal levels approximately 6 weeks after the 
operation. 
In the present group of experiments, there 18 no direct evidence either 
for or against the hypothesis that collateral sprouting of post-ganglionic 
sympathetic fibers may be taking place. It is also not known what would 
consUtue an adequate sttmulus to the post-ganglionic fibers from the 
contralateral sympathetic tnmk in order to initiate eolbteral sprouting. 
In the 3nimals which were subjected to a bUateral sympathectomy, 
the catecholamine levels were not reduced to zero ~s might at first glanee 
be exptcted. In fact, as 9. whole. the catechobmine levels of the bilaterally 
sympathectomlzed animals were not much lower than those of the unibteral-
ly sympathectomized animals. These results are not surprizing in the light 
of the data reported by Cooper in which he compared the effects of a bilateral 
cervico-thorac1e sympa.thectomy with those of a complete cardiac denervatim 
involving surgle al removal of the heart followed by autotransplantation. In 
his study, the average left ventr1eular catecholamine content of control 
dogs was 0.71 ugm per gram of tissue with a range from 0.57 to 0.97 ugm 
per gram. The average catecholamine level in the left ventricle of dogs 
which underwent a bilateral cervico-thorac1c sympathectomy was 0.49 ugm 
per gram of tissue with a range from O. 41 to O. 62 ugm per gram. However, 
in the left ventricle of dogs StJ.bjected to a complete cardiac denervation, 
there was less than O. 05 ugm of catecholamine. per gram of tissue (54). 
Thus It can be seen that the bUateral sympathectomy as performed in the 
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present experiments is not sufficiently complete to cause a 100% depletion of 
cateeholamine levels in the heart. 
The data obtained from the control animals point to the fact that impor-
tant dUferences in catecholamine content exist between the various regions 
of the heart. The average levels in the control group of animals were as 
follows: 
RA 
1.46 
:0.33 
L}' 
1.13 
! O. 40 
RV 
0.78 
:!: o. 23 
LVA 
0.64 
:0.25 
LVB 
0.62 
~. o. 20 
S 
0.67 
!. O. 23 
An analysts of this data revealed that the catecholamine content of the 
atria was significantly higher than that of the ventrtcles. The difference 
between the combined atrial catecholamine level and the combine d ventricular 
level was statistically significant. The p-value was less than O. 001. In 
every control animal, the catecholamine level was markedly higher in the 
atrium than in the ipsilateral ventrlele. Likewise in the sham operated 
animals, the atrial level was in every instance higher than that of the ipsi-
lateral velltric1e. An p.nalys:t.8 of the data from the unilaterally sympathec-
tomized animals showed that the level in the atrium was higher tlutn that in 
the tpsilnteral ventrtcle in all but 9 out of 104 comparisons. This high 
concentration of catecholamines in atrial tissues is not surpttzing in view 
of the profound chronotropiC activity of the sympathettc nerves and also the 
occurrence of marked augmentation in foree of contraction of both atria 
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during stellate stimulation as evidenced by the elevation of the A-wave in the 
atrial pressure recording. 
The concentration of catecholamines in the ventricular walls in the 
control animal is approximately 50% of that found in the atria, when rePlrted 
as micrograms per gram of tissue. However this sympathetic innervation 
to the ventricles is extremely important, as evidenced by the p:>werful 
augmentation in force of contraction as a result of stellate stimulation. 
In most of the hearts from the control animals, the catecholamine level 
was higher bl the right atrium than in the left, and it was also generally 
higher in the right ventricle tMn in the left. The difference between the 
right and left atrial levels and between the right and left ventricular levels 
did not prove to be statistically stgnUlcant, however; the p-value W8S 
a.pproximately 0.10. These findings a.re in agreement with the data of 
Muscholl (200). In his study t he determined the amounts of norepinephrine 
and epinephrine 1n the various parts of the he2rts of cats, rabbits, guinea. 
pigs, and rats. In each of these spec ies he found that the norepinephrine 
concentration was much higher in the right atrium than in the left and it 
was also higher in the right than in the left ventrlcle. To this data it may 
now be added that in the dog also there tends to be a higher catecholamine 
level on the right side of the heart than on the left. 
One of the purposes of thts investigation was ttl demonstrate a correlatlon 
between a catecholamine deficit as determined by the chemical analysis and 
a functional deficit as determined by the four-chamber pressure recordings. 
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It was theorized that the loss of the cardiae sympathetic transmitter as a 
result of the sympathectomy could be correlated with a proporttonalloss 
in cardiac function. However it was found thRt this correl~tion W3,S often 
$lbsent when individual ~nlmpls were studied. Tn mMy Insbnces, animals 
showing a. significant cptechol~mine deficit gnve good functional resJX)nses 
while animflls retaining near-normal catechobmine levels ga.ve very poor 
:functional responses. It 1s eVident, therefore, that no direct relationship 
between catecholamine content And cardiae function can be made at the 
present time utUtzing these data. 
CHAPTER V 
stTl'J.!M.ARY 
In an attempt to determine how much tnfluence is exerted independently 
by the right Md the left cardiac symp~thetic nerves, a unUateral cardiac 
sympathectomy was performed. A t v~r1ous periods of time after the 
sympathectomy, the intact contrru.~teral stel1~te glIlglion was electrlc~lly 
stimulated and pressure recordings were tlken from the four ch~mbers of 
the heart. "lbe content of norepinephrine $tnd epinephrine in each of the 
four chambers and the septum was determined using the trl-hydroxy indole 
fluorimetrtc analysts. 
The experimental results obtained were compared with data from control 
animals. The catecholamine content for control anlr.tlals was as follows: 
RA I .. A RV t,VA LVB S 
1. 46 ug/gm 1. 13 ug/gin 0.78 ug/grn O. 64 ug/gm O. 62 ug/g!n O. 67ug~ 
The figures sited are the average values for a group of eight control 
animals. The catecholamine content of the atrium was always markedly 
higher than that of the ipsilateral ventricle. The difference between the 
combined atrial catecholamine level and the combined ventricular cate-
cholamine level was statistically slgnUlcant (p O. 001). In most of the hearts 
from control Qnlmals, the cetechommine level was higher in the right atrium 
thsn in the left, ~md it WllS nlso gener~lly higher in the right ventricle than 
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in the left. These differences, however, were not statistically significant. 
Shrtm-operltted smimm had eatecholamhle levels which did not differ 
significAntly from those of control animals. This indicates that the operation 
itself had no effect on the cardiac catecholamine content. 
Although tCere is some v~:tabUity :':'!mong nnilnals, the unilaterally 
syrnl-"I9thectomized animals definitely gave an abnormal response to stellate 
stbnulation. when studied vlithin 2 weeks following the operation. In many 
cases the augmentation l1sually seen w::ts much reduced or absent. When a 
full response did occur, it W3S frequently characterized by a considerable 
delay between the initiation of the stimulation rutd the attainment of maximum 
response. When functional studies were made on. animals 6 or 7 weeks after 
the btltial operation, the resIXlnses were compar'-"!ble to those obtained from 
:;: normal animru.. It is postuhrted th~t reinnerv,-Uon. of the heart ~.ccounts 
for this retu.rn to the norm~l picture. 
An ':Innlys18 of the cntechol~mine d~b obtained from the unilaterally 
sympathectomized "nimpls showed that the most m~rk.d reduction in 
c atecholamtne levels occurred in those animals which were studied within 
one week ~fter the initial operation. 'l"b.e catecholamine content wa.s reduced 
by the operation to about 50% of the control level. By 6 weeks after the 
operation, however, the catecholamine content had again increased and the 
levels were not significantly different from the levels in the control animals. 
The effect of a right sympathectomy was to reduce the catecholarlline 
content of the right atrium, the right ventricle, and the septum, with only 
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'"' slight effect on the left ventricle ~nd very Uttle or no effect on the left 
atrium. A left sympathectomy, on the other hrutd, brought about a reduction 
in the catecholamine content of the entire heart with the exception of the left 
atrium. The catecholamine level of the left atrium was not significantly 
affected by either operation. 
The fact that the animals studied 6 weeks after the initial operation 
demonstrate a normal catecholamine content and a normal functional 
response indicates that some reinnervation of the heart has occurred. For 
reasons etated in Chapter IV, it Is postulated that this reinJlervatlon may 
take place by means of collateral sprouting of the intact post-ganglionlc 
sympathetic fibers from the contralateral side. 
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